<?xml version="1.0" encoding="UTF-8"?>
<Record
    xmlns="http://pubchem.ncbi.nlm.nih.gov/pug_view"
    xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
    xs:schemaLocation="http://pubchem.ncbi.nlm.nih.gov/pug_view https://pubchem.ncbi.nlm.nih.gov/pug_view/pug_view.xsd"
>
  <RecordType>CID</RecordType>
  <RecordNumber>358641</RecordNumber>
  <RecordTitle>Sulfamethoxazole and trimethoprim</RecordTitle>
  <Section>
    <TOCHeading>Structures</TOCHeading>
    <Description>Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.</Description>
    <Section>
      <TOCHeading>2D Structure</TOCHeading>
      <Description>A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (HÃ¤hnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  </Description>
      <URL>https://doi.org/10.1186/s13321-018-0293-8</URL>
      <DisplayControls>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <Boolean>true</Boolean>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>3D Status</TOCHeading>
      <Description>The reason why three-dimensional (3D) conformers for this compound cannot be generated.  PubChem generates 3D conformers for each compound that satisfies the following conditions: [1] not too large (with &lt;= 50 non-hydrogen atoms), [2] not too flexible (with &lt;= 15 rotatable bonds), [3] consisting of only supported elements (H, C, N, O, F, Si, P, S, Cl, Br, and I), [4] having only a single covalent unit (i.e., not a salt or a mixture), [5] contains only atom types recognized by the MMFF94s force field used for conformer generation, and [6] has fewer than six undefined atom or bond stereo centers.  Compounds that do not satisfy any of these conditions are not considered for 3-D conformer generation.  In some rare cases, a compound satisfies all conditions but the conformer generation for the compound fails for some reason. More detailed information on 3D conformer generation can be found in Kim et al., J. Cheminform. 2013, 5, 1.</Description>
      <URL>https://doi.org/10.1186/1758-2946-5-1</URL>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Conformer generation is disallowed since mixture or salt</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Names and Identifiers</TOCHeading>
    <Description>Chemical names, synonyms, identifiers, and descriptors.</Description>
    <Section>
      <TOCHeading>Record Description</TOCHeading>
      <Description>Summary Information</Description>
      <DisplayControls>
        <HideThisSection>true</HideThisSection>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>8</ReferenceNumber>
        <Description>HIV/AIDS and Opportunistic Infection Drugs</Description>
        <Value>
          <StringWithMarkup>
            <String>Sulfamethoxazole/trimethoprim is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain infections, such as:</String>
            <Markup>
              <Start>0</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>17</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Chronic bronchitis</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Urinary tract and acute ear infections</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Enteric infections, including shigellosis and traveler&apos;s diarrhea</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Pneumocystis pneumonia (PCP)</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Sulfamethoxazole/trimethoprim is also FDA-approved to prevent PCP in people who are immunosuppressed and are at risk of developing PCP.</String>
            <Markup>
              <Start>0</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>17</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Certain bacterial infections and PCP can be opportunistic infections (OIs) of HIV.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>20</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Trimethoprim-Sulfamethoxazole is a synthetic combination of two antibacterial agents, trimethoprim and sulfamethoxazole. This synergistic combination, also known as Co-Trimoxazole, inhibits two sequential steps in the bacterial metabolism of folic acid. Trimethoprim is a pyrimidine inhibitor of dihydrofolate reductase; sulfamethoxazole is a sulfamide inhibitor of bacterial dihydrofolate synthase.</String>
            <Markup>
              <Start>0</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim-Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>86</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>103</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>165</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Co-Trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>242</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398658</Extra>
            </Markup>
            <Markup>
              <Start>254</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>272</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/pyrimidine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-9260</Extra>
            </Markup>
            <Markup>
              <Start>296</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/dihydrofolate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
            <Markup>
              <Start>321</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>343</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamide</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-82267</Extra>
            </Markup>
            <Markup>
              <Start>376</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/dihydrofolate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>28</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Computed Descriptors</TOCHeading>
      <Description>Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.</Description>
      <Section>
        <TOCHeading>IUPAC Name</TOCHeading>
        <Description>Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.</Description>
        <URL>https://iupac.org/what-we-do/nomenclature/</URL>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by Lexichem TK 2.7.0 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine</String>
              <Markup>
                <Start>8</Start>
                <Length>1</Length>
                <Type>Italics</Type>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>InChI</TOCHeading>
        <Description>The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.</Description>
        <URL>https://iupac.org/who-we-are/divisions/division-details/inchi/</URL>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by InChI 1.0.6 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>InChI=1S/C14H18N4O3.C10H11N3O3S/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h5-7H,4H2,1-3H3,(H4,15,16,17,18);2-6H,11H2,1H3,(H,12,13)</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>InChIKey</TOCHeading>
        <Description>An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. </Description>
        <URL>https://iupac.org/who-we-are/divisions/division-details/inchi/</URL>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by InChI 1.0.6 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>WZRJTRPJURQBRM-UHFFFAOYSA-N</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Canonical SMILES</TOCHeading>
        <Description>The Simplified Molecular-Input Line-Entry System (SMILES) is a widely-used line notation for chemical structures.  PubChem computes two kinds of SMILES strings for compounds: canonical SMILES (computed from chemical structures devoid of isotopic and stereochemical information), and isomeric SMILES (computed from chemical structures containing isotopic and stereochemical information).  This section shows the canonical SMILES of the compound.</Description>
        <URL>https://www.daylight.com/dayhtml/doc/theory/theory.smiles.html</URL>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by OEChem 2.3.0 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N.COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Molecular Formula</TOCHeading>
      <Description>A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.</Description>
      <URL>https://pubs.acs.org/doi/abs/10.1021/ja02046a005</URL>
      <DisplayControls>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Reference>Computed by PubChem 2.1 (PubChem release 2021.05.07)</Reference>
        <Value>
          <StringWithMarkup>
            <String>C24H29N7O6S</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Other Identifiers</TOCHeading>
      <Description>Other identifiers assigned to this chemical.</Description>
      <Section>
        <TOCHeading>CAS</TOCHeading>
        <Description>A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.</Description>
        <URL>https://www.cas.org/support/documentation/chemical-substances/faqs</URL>
        <Information>
          <ReferenceNumber>1</ReferenceNumber>
          <URL>https://commonchemistry.cas.org/detail?cas_rn=8064-90-2</URL>
          <Value>
            <StringWithMarkup>
              <String>8064-90-2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>4</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>8064-90-2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>12</ReferenceNumber>
          <Name>CAS</Name>
          <Value>
            <StringWithMarkup>
              <String>8064-90-2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>13</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>8064-90-2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>8064-90-2</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Related CAS</TOCHeading>
        <Description>The Chemical Abstract Service (CAS) registry numbers for related chemicals (e.g., parents, components, mixtures, salt forms, etc.)</Description>
        <Information>
          <ReferenceNumber>2</ReferenceNumber>
          <Reference>Compound: Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, compd. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine (1:1)</Reference>
          <URL>https://commonchemistry.cas.org/detail?cas_rn=73306-81-7</URL>
          <Value>
            <StringWithMarkup>
              <String>73306-81-7</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Deprecated CAS</TOCHeading>
        <Description>The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.</Description>
        <Information>
          <ReferenceNumber>4</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>74711-00-5, 117385-88-3, 37341-72-3, 38916-35-7, 50641-67-3, 50808-41-8, 52499-85-1, 8064-91-3, 8076-73-1</String>
              <Markup>
                <Start>61</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/50808-41-8</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>13</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>117385-88-3, 37341-72-3, 38916-35-7, 39422-07-6, 50641-67-3, 50808-41-8, 52499-85-1, 74711-00-5, 8064-91-3, 8064-92-4, 8076-73-1</String>
              <Markup>
                <Start>61</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/50808-41-8</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>NSC Number</TOCHeading>
        <Description>The National Service Center (NSC) number is a numeric identifier for substances submitted to the National Cancer Institute (NCI) for testing and evaluation. It is a registration number for the Developmental Therapeutics Program (DTP) repository.</Description>
        <URL>https://dtp.cancer.gov/organization/dscb/compoundSubmission/faqs.htm</URL>
        <Information>
          <ReferenceNumber>12</ReferenceNumber>
          <Name>NSC Number</Name>
          <URL>https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&amp;outputformat=html&amp;searchlist=618652</URL>
          <Value>
            <StringWithMarkup>
              <String>618652</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>DSSTox Substance ID</TOCHeading>
        <Description>Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.</Description>
        <URL>https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database</URL>
        <Information>
          <ReferenceNumber>13</ReferenceNumber>
          <URL>https://comptox.epa.gov/dashboard/DTXSID0032233</URL>
          <Value>
            <StringWithMarkup>
              <String>DTXSID0032233</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Wikipedia</TOCHeading>
        <Description>Wikidata entity identifier for this compound.</Description>
        <Information>
          <ReferenceNumber>27</ReferenceNumber>
          <URL>https://en.wikipedia.org/wiki/Trimethoprim/sulfamethoxazole</URL>
          <Value>
            <StringWithMarkup>
              <String>Trimethoprim/sulfamethoxazole</String>
              <Markup>
                <Start>0</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim%2Fsulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Wikidata</TOCHeading>
        <Description>Wikidata entity identifier for the given compound.</Description>
        <URL>https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662</URL>
        <Information>
          <ReferenceNumber>26</ReferenceNumber>
          <URL>https://www.wikidata.org/wiki/Q898623</URL>
          <Value>
            <StringWithMarkup>
              <String>Q898623</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>NCI Thesaurus Code</TOCHeading>
        <Description>Stable, unique code for biomedical concept</Description>
        <URL>https://ncithesaurus.nci.nih.gov</URL>
        <Information>
          <ReferenceNumber>20</ReferenceNumber>
          <URL>https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C909</URL>
          <Value>
            <StringWithMarkup>
              <String>C909</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>ChEMBL ID</TOCHeading>
        <Description>ChEMBL compound identifier</Description>
        <URL>https://www.ebi.ac.uk/chembl/</URL>
        <Information>
          <ReferenceNumber>3</ReferenceNumber>
          <URL>https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL58061/</URL>
          <Value>
            <StringWithMarkup>
              <String>CHEMBL58061</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>KEGG ID</TOCHeading>
        <Description>KEGG compound/drug identifier</Description>
        <URL>https://www.kegg.jp/</URL>
        <Information>
          <ReferenceNumber>17</ReferenceNumber>
          <URL>https://www.kegg.jp/entry/D00285</URL>
          <Value>
            <StringWithMarkup>
              <String>D00285</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Synonyms</TOCHeading>
      <Description>Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.</Description>
      <Section>
        <TOCHeading>MeSH Entry Terms</TOCHeading>
        <Description>Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.</Description>
        <URL>http://doi.org/10.1186/s13321-016-0142-6</URL>
        <DisplayControls>
          <ListType>Columns</ListType>
        </DisplayControls>
        <Information>
          <ReferenceNumber>28</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Abactrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactifor</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Biseptol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Biseptol 480</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Biseptol-480</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Biseptol480</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Centran</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Centrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Co Trimoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Co-Trimoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Drylin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Eslectin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Eusaprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Insozalin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kepinol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kepinol Forte</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Lescot</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Metomide</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Oriprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Septra</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Septrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole Trimethoprim Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole-Trimethoprim Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sumetrolim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TMP SMX</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TMP-SMX</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimedin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim Sulfamethoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim Sulfamethoxazole Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim, Sulfamethoxazole Drug Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim-Sulfamethoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim-Sulfamethoxazole Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprimsulfa</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimezole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimosulfa</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Depositor-Supplied Synonyms</TOCHeading>
        <Description>Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.</Description>
        <DisplayControls>
          <ListType>Columns</ListType>
          <MoveToTop>true</MoveToTop>
        </DisplayControls>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>sulfamethoxazole &amp; trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>sulfamethoxazole + trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CO-Trimoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimosulfa</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>8064-90-2</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprimsulfa</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimforte</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole-trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim-sulfamethoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TMP-SMX</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SULFAMETHOXAZOLE AND TRIMETHOPRIM</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Gantrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim-sulfamethoxazole combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TRIMETHOPRIM/SULFAMETHOXAZOLE</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TMP/SMX</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim and sulphamethoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole Trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole / trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim and sulfamethoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>A 033</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NSC618652</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Abactrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Biseptol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Oriprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kepinol Forte</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:19)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Aposulfatrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactoreduct</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimhexal</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimoxazol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimstada</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Duratrimet</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Jenamoxazol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfotrimin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimetoger</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimexazol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Agoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Alfatrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bacteral</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactilen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactiver</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactrizol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactromin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactropin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Berlocid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bibacrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Chemitrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotribene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotriver</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dibaprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Eltrianyl</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Escoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Esteprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Gantaprin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Groprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Helveprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kemoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Linaris</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Maxtrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Mikrosid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Momentol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Oecotrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Oxaprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Pantoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Primazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Septrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Septrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Servitrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sigaprin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tacumil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Teleprin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tribakin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bacton</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ciplin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Omsat</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trifen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bacterial forte</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Microtrim forte</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Duon</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimetho comp</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimox-Wolff</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactrim Forte</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Co-Trimaxazol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim Holsen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimoxazol AL</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim-Puren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Strepto-Plus</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim-Hefa</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimexole-F</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Baktrisid-DS</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Co-trim-tablinen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim-radiopharm</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfa-Tyl</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfameth/TMP</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfameth/Trimeth</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim Eu Rho</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim_BASF</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrimoxazol-Cophar</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide compound with 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine (1:1)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim.L.U.T.</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SMX-TMP</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SMX/TMP</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole-trimeth</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole / TMP</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SMX / TMP</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TMP / SMX</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Co-Trimazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HSDB 6780</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TMS 480</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NSC 618652</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Co-Trimoxazole (BAN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Epitope ID:141805</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TMP &amp; SMX</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim, Sulfamethoxazole Drug Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHEMBL58061</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SCHEMBL870329</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim &amp; Sulfamethoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHEBI:3770</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DTXSID0032233</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>WZRJTRPJURQBRM-UHFFFAOYSA-N</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HY-141619A</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NSC-618652</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzenesulfonamide, 4-a)mino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl-2,4-pyrimidinediamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CS-0885981</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>D00285</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Q898623</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzenesulfonamide, mixt. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4- pyrimidinediamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>50808-41-8</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)- &amp; 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SXT</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Removed Synonyms</TOCHeading>
        <Description>Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.</Description>
        <DisplayControls>
          <HideThisSection>true</HideThisSection>
        </DisplayControls>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Bactrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Septra</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfatrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulmeprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sumetrolim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Eusaprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kepinol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Drylin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimeth/Sulfa</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Septra Grape</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfatrim-Ds</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfatrim-Ss</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Supracombin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactramin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Chemotrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Diseptyl</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Gantaprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Laratrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Microtrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sigaprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfotrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Teleprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Thiocuran</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trigonyl</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimesulf</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Centrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fectrim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Uroplus</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Abacin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Baktar</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Imexim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Suprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Septra Ds</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Acuco</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Comox</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nopil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactrim Pediatric</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactrim DS</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Uroplus DS</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Uroplus SS</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoprim-DS</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Uro-Septra</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfatrim Pediatric</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulmeprim Pediatric</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactifor</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Eslectin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Insozalin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Metomide</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimedin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimezole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Centran</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Centrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Lescot</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Co Trimoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cotrim D.S.</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tmp Smx</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Biseptol480</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bactrim (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Biseptol 480</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Biseptol-480</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Septra (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>COTRIM D.S</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazol-trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AC1L7D1P</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole/Trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim Sulfamethoxazole</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole &amp; Trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CTK4J2930</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole mixture with trimethoprim</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CID358641</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SULFAMETHOXAZOLE; TRIMETHOPRIM</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>C14H18N4O3.C10H11N3O3S</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AKOS030548395</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole - trimethoprim mixture</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole Trimethoprim Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole-Trimethoprim Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trimethoprim Sulfamethoxazole Combination</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>LS-178642</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>D015662</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>C14-H18-N4-O3.C10-H11-N3-O3-S</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-AMINO-N-(5-METHYL-3-ISOXAZOLYL)-BENZENESULFONAMIDE COMPOUND WITH 5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE-2,4-DIAMINE</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>50641-67-3</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixture with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)- and N&apos;-(5-methyl-3-isoxazolyl)sulfanilamide</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Create Date</TOCHeading>
      <Description>Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/docs/record-dates</URL>
      <DisplayControls>
        <HideThisSection>true</HideThisSection>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <DateISO8601>2005-03-26</DateISO8601>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Modify Date</TOCHeading>
      <Description>Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/docs/record-dates</URL>
      <DisplayControls>
        <HideThisSection>true</HideThisSection>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <DateISO8601>2023-10-03</DateISO8601>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Chemical and Physical Properties</TOCHeading>
    <Description>Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.</Description>
    <Section>
      <TOCHeading>Computed Properties</TOCHeading>
      <Description>Properties of this compound computed from its molecular formula and structure.</Description>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>Subsections</FromInformationIn>
          <NumberOfColumns>3</NumberOfColumns>
          <ColumnHeadings>Property Name</ColumnHeadings>
          <ColumnHeadings>Property Value</ColumnHeadings>
          <ColumnHeadings>Reference</ColumnHeadings>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
          <ColumnContents>Reference</ColumnContents>
        </CreateTable>
      </DisplayControls>
      <Section>
        <TOCHeading>Molecular Weight</TOCHeading>
        <Description>Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).</Description>
        <URL>https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en</URL>
        <DisplayControls>
          <MoveToTop>true</MoveToTop>
        </DisplayControls>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem 2.1 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>543.6</String>
            </StringWithMarkup>
            <Unit>g/mol</Unit>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Hydrogen Bond Donor Count</TOCHeading>
        <Description>The number of hydrogen bond donors in this compound.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>4</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Hydrogen Bond Acceptor Count</TOCHeading>
        <Description>The number of hydrogen bond acceptors in this compound.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>13</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Rotatable Bond Count</TOCHeading>
        <Description>A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>8</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Exact Mass</TOCHeading>
        <Description>The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem 2.1 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>543.19000284</String>
            </StringWithMarkup>
            <Unit>g/mol</Unit>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Monoisotopic Mass</TOCHeading>
        <Description>The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem 2.1 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>543.19000284</String>
            </StringWithMarkup>
            <Unit>g/mol</Unit>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Topological Polar Surface Area</TOCHeading>
        <Description>The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.</Description>
        <URL>https://pubmed.ncbi.nlm.nih.gov/11020286/</URL>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>212</Number>
            <Unit>â«Â²</Unit>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Heavy Atom Count</TOCHeading>
        <Description>The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>38</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Formal Charge</TOCHeading>
        <Description>Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Complexity</TOCHeading>
        <Description>The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.</Description>
        <URL>https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity</URL>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>653</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Isotope Atom Count</TOCHeading>
        <Description>Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Defined Atom Stereocenter Count</TOCHeading>
        <Description>An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The &quot;defined atom stereocenter count&quot; is the number of atom stereocenters whose configurations are specifically defined.  </Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Undefined Atom Stereocenter Count</TOCHeading>
        <Description>The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the &quot;defined atom stereocenter count&quot; above.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Defined Bond Stereocenter Count</TOCHeading>
        <Description>A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The &quot;defined bond stereocenter count&quot; is the number of bond stereocenters whose configurations are specifically defined.  </Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Undefined Bond Stereocenter Count</TOCHeading>
        <Description>The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the &quot;defined bond stereocenter count&quot; above.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Covalently-Bonded Unit Count</TOCHeading>
        <Description>A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The &quot;covalently-bonded unit count&quot; property is the number of such units in this compound compound.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>2</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Compound Is Canonicalized</TOCHeading>
        <Description>Whether the compound has successfully passed PubChem&apos;s valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process.</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Reference>Computed by PubChem (release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Yes</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Related Records</TOCHeading>
    <Description>Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.</Description>
    <Section>
      <TOCHeading>Related Compounds with Annotation</TOCHeading>
      <Description>Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the &quot;Related Compounds&quot; section below this section.  The &quot;Related Compounds&quot; include the parent, components, mixtures, and salt forms of this compound record as well as the &quot;similar compounds&quot; and &quot;similar conformers&quot;, which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.</Description>
      <URL>https://doi.org/10.1186/s13321-016-0163-1</URL>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <Boolean>true</Boolean>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Component Compounds</TOCHeading>
      <Description>Component parts of the compound when it consists of multiple covalently-bonded units.  In PubChem, a covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or single atom without covalent bonds).</Description>
      <DisplayControls>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>CID 5578 (Trimethoprim)</String>
            <Markup>
              <Start>0</Start>
              <Length>23</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&amp;cid=5578</URL>
              <Type>Icon</Type>
            </Markup>
            <Markup>
              <Start>0</Start>
              <Length>23</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/5578</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID 5329 (Sulfamethoxazole)</String>
            <Markup>
              <Start>0</Start>
              <Length>27</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&amp;cid=5329</URL>
              <Type>Icon</Type>
            </Markup>
            <Markup>
              <Start>0</Start>
              <Length>27</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/5329</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Related Compounds</TOCHeading>
      <Description>Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the &quot;similar compounds&quot; and &quot;similar conformers&quot;, which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.</Description>
      <URL>https://doi.org/10.1186/s13321-016-0163-1</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>1</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>Mixtures, Components, and Neutralized Forms Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/358641/cids/JSON?cids_type=component&amp;list_return=redirect</URL>
        <Value>
          <Number>2</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>Similar Compounds Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/358641/cids/JSON?cids_type=similar_2d&amp;list_return=redirect</URL>
        <Value>
          <Number>11</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Substances</TOCHeading>
      <Description>Substance records associated with this compound.  In PubChem, the term &quot;substance&quot; refers to depositor-provided data for a chemical..</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/docs/substances</URL>
      <Section>
        <TOCHeading>Related Substances</TOCHeading>
        <Description>Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).</Description>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>1</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Name>Same Count</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/358641/sids/JSON?sids_type=standardized&amp;list_return=redirect</URL>
          <Value>
            <Number>49</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Substances by Category</TOCHeading>
        <Description>Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).</Description>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Chemical Vendors</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Curation Efforts</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Governmental Organizations</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Journal Publishers</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Legacy Depositors</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NIH Initiatives</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Research and Development</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Subscription Services</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Entrez Crosslinks</TOCHeading>
      <Description>Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.</Description>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>1</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>PubMed Count</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&amp;db=pccompound&amp;cmd=Link&amp;from_uid=358641</URL>
        <Value>
          <Number>221</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>Taxonomy Count</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&amp;db=pccompound&amp;cmd=Link&amp;from_uid=358641</URL>
        <Value>
          <Number>160</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>OMIM Count</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_omim&amp;db=pccompound&amp;cmd=Link&amp;from_uid=358641</URL>
        <Value>
          <Number>12</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>Gene Count</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&amp;db=pccompound&amp;cmd=Link&amp;from_uid=358641</URL>
        <Value>
          <Number>1</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>NCBI LinkOut</TOCHeading>
      <Description>NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.</Description>
      <URL>https://www.ncbi.nlm.nih.gov/projects/linkout/</URL>
      <Information>
        <ReferenceNumber>49</ReferenceNumber>
        <Value>
          <Boolean>true</Boolean>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Chemical Vendors</TOCHeading>
    <Description>A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor&apos;s website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor&apos;s website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  </Description>
    <Information>
      <ReferenceNumber>29</ReferenceNumber>
      <Value>
        <Boolean>true</Boolean>
      </Value>
    </Information>
  </Section>
  <Section>
    <TOCHeading>Drug and Medication Information</TOCHeading>
    <Description>This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.</Description>
    <Section>
      <TOCHeading>WHO Essential Medicines</TOCHeading>
      <Description>The WHO Essential Medicines present a list of minimum medicine needs for a basic health-care system, listing the most efficacious, safe and cost-effective medicines for priority conditions.</Description>
      <URL>https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>4</NumberOfColumns>
          <ColumnsFromNamedLists>
            <Name>Drug</Name>
            <Name>Drug Classes</Name>
            <Name>Formulation</Name>
            <Name>Indication</Name>
            <UseNamesAsColumnHeadings>true</UseNamesAsColumnHeadings>
          </ColumnsFromNamedLists>
        </CreateTable>
        <ShowAtMost>3</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>25</ReferenceNumber>
        <Name>Drug</Name>
        <Value>
          <StringWithMarkup>
            <String>Sulfamethoxazole + trimethoprim</String>
            <Markup>
              <Start>0</Start>
              <Length>31</Length>
              <URL>https://list.essentialmeds.org/medicines/334</URL>
            </Markup>
            <Markup>
              <Start>0</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>19</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Sulfamethoxazole + trimethoprim</String>
            <Markup>
              <Start>0</Start>
              <Length>31</Length>
              <URL>https://list.essentialmeds.org/medicines/334</URL>
            </Markup>
            <Markup>
              <Start>0</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>19</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>25</ReferenceNumber>
        <Name>Drug Classes</Name>
        <Value>
          <StringWithMarkup>
            <String>Access group antibiotics</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Antipneumocystosis and antitoxoplasmosis medicines</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>25</ReferenceNumber>
        <Name>Formulation</Name>
        <Value>
          <StringWithMarkup>
            <String>(1) Parenteral - General injections - IV: 80 mg + 16 mg per  mL in 10 mL ampoule; 80 mg + 16 mg per  mL in 5 mL ampoule; (2) Oral - Liquid: 200 mg + 40 mg per 5 mL oral liquid; (3) Oral - Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>(1) Parenteral - General injections - IV: 80 mg + 16 mg per  mL in 5 mL ampoule; 80 mg + 16 mg per  mL in 10 mL ampoule; (2) Oral - Liquid: 200 mg + 40 mg per 5 mL oral liquid; (3) Oral - Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>25</ReferenceNumber>
        <Name>Indication</Name>
        <Value>
          <StringWithMarkup>
            <String>(1) Infectious cystitis [co-prescribed with J01EE01]; (2) Infectious gastroenteritis or colitis without specification of infectious agent [co-prescribed with J01EE01]; (3) Bacterial infection of unspecified site [co-prescribed with J01EE01]</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Pneumocystosis [co-prescribed with J01EE01]</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Approved Drugs</TOCHeading>
      <Description>Drugs@FDA includes information about approved drugs and biological products for human use in the United States.</Description>
      <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda</URL>
      <Information>
        <ReferenceNumber>11</ReferenceNumber>
        <Value>
          <ExternalTableName>fdadrug</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Orange Book</TOCHeading>
      <Description>The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.</Description>
      <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
      <Information>
        <ReferenceNumber>15</ReferenceNumber>
        <Value>
          <ExternalTableName>fdaorangebook</ExternalTableName>
          <ExternalTableNumRows>46</ExternalTableNumRows>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>HIV/AIDS and Opportunistic Infection Drugs</TOCHeading>
      <Description>This section contains information and links on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.</Description>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
      </DisplayControls>
      <Information>
        <ReferenceNumber>8</ReferenceNumber>
        <Name>What is Sulfamethoxazole / Trimethoprim</Name>
        <Value>
          <StringWithMarkup>
            <String>Sulfamethoxazole/trimethoprim is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain infections, such as:</String>
            <Markup>
              <Start>0</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>17</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Chronic bronchitis</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Urinary tract and acute ear infections</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Enteric infections, including shigellosis and traveler&apos;s diarrhea</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Pneumocystis pneumonia (PCP)</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Sulfamethoxazole/trimethoprim is also FDA-approved to prevent PCP in people who are immunosuppressed and are at risk of developing PCP.</String>
            <Markup>
              <Start>0</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>17</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Certain bacterial infections and PCP can be opportunistic infections (OIs) of HIV.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>8</ReferenceNumber>
        <Name>Drug Class</Name>
        <Value>
          <StringWithMarkup>
            <String>Antibacterial (Sulfonamide/Dihydrofolate Reductase Inhibitor)</String>
            <Markup>
              <Start>27</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Dihydrofolate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Clinical Trials</TOCHeading>
      <Description>Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.</Description>
      <Section>
        <TOCHeading>ClinicalTrials.gov</TOCHeading>
        <Description>Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.</Description>
        <URL>http://clinicaltrials.gov/</URL>
        <Information>
          <ReferenceNumber>6</ReferenceNumber>
          <Name>ClinicalTrials.gov</Name>
          <Value>
            <ExternalTableName>clinicaltrials</ExternalTableName>
            <ExternalTableNumRows>105</ExternalTableNumRows>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>EU Clinical Trials Register</TOCHeading>
        <Description>Brief clinical trials summary from the EU Clinical Trials Register.</Description>
        <URL>https://www.clinicaltrialsregister.eu/</URL>
        <Information>
          <ReferenceNumber>14</ReferenceNumber>
          <Name>EU Clinical Trials Register</Name>
          <Value>
            <ExternalTableName>clinicaltrials_eu</ExternalTableName>
            <ExternalTableNumRows>29</ExternalTableNumRows>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Therapeutic Uses</TOCHeading>
      <Description>Therapeutic uses information for this compound, provided by the Hazardous Substances Data Bank (HSDB).</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>QC REVIEWED</Description>
        <Reference>National Library of Medicine&apos;s Medical Subject Headings online file (MeSH, 1999)</Reference>
        <Value>
          <StringWithMarkup>
            <String>Anti-Infective Agents; Anti-Infective Agents, Urinary; Antimalarials</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1992 (Plus Supplements 1992)., p. 463</Reference>
        <Value>
          <StringWithMarkup>
            <String>Co-trimoxazole has been used in the treatment of gonorrhea caused by penicillinase-producing Neisseria gonorrhoeae. Although other anti-infective agents are generally recommended by the US Centers for Disease Control and many clinicians for the treatment of urogenital or anorectal infections caused by penicillinase-producing Neisseria gonorrhoeae, co-trimoxazole may be effective for the treatment of pharyngeal infections caused by penicillinase-producing Neisseria gonorrhoeae Although clinical experience is limited, oral co-trimoxazole may also be effective as an alternative to currently recommended regimens for the treatment of acute sexually transmitted epididymitis caused by penicillinase-producing Neisseria gonorrhoeae.</String>
            <Markup>
              <Start>0</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Co-trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>350</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/co-trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>527</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/co-trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1345</Reference>
        <Value>
          <StringWithMarkup>
            <String>Trimethoprim/sulfamethoxazole is an alternative to tetracycline in cholera. This combination is recommended in isosporiasis (Isospora belli).</String>
            <Markup>
              <Start>0</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/tetracycline</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-54675776</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1346</Reference>
        <Value>
          <StringWithMarkup>
            <String>Trimethoprim/sulfamethoxazole may be useful in serious infections, including meningitis, osteomyelitis, bacteremia, and endocarditis, caused by susceptible gram-negative bacteria when other antibacterial agents are ineffective or not tolerated. Of particular note, gram-negative bacillary meningitis caused by organisms only moderately susceptible to third generation cephalosporins (eg, Enterobacter cloacae, Serratia marcescens) or resistant to these antibiotics (Acinetobacter, Pseudomonas cepacia) may be candidates for trimethoprim/sulfamethoxazole therapy if the organisms are susceptible. This combination may be an effective alternative to ampicillin (or penicillin G) with or without an aminoglycoside for the treatment of meningitis and bacteremia caused by Listeria monocytogenes. Trimethoprim/sulfamethoxazole may be useful for the treatment of infective endocarditis caused by Coxiella burnetii. In a double-blind, randomized, prospective study, intravenous trimethoprim/sulfamethoxazole (640 mg/3200 mg daily) was shown to be as effective as vancomycin in the treatment of serious methicillin-resistant Staphylococcus aureus infections, including bacteremias, endocarditis, septic arthritis, and osteomyelitis. The details of this study have not been published, however, and some consultants expressed concern about the use of trimethoprim/sulfamethoxazole in deep-seated staphylococcal infections (eg, endocarditis) because this combination may only be bacteriostatic against this organism. Currently, each of these indications is considered investigational.</String>
            <Markup>
              <Start>0</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>524</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>648</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ampicillin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6249</Extra>
            </Markup>
            <Markup>
              <Start>663</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/penicillin%20G</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5904</Extra>
            </Markup>
            <Markup>
              <Start>792</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>971</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>1056</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/vancomycin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-14969</Extra>
            </Markup>
            <Markup>
              <Start>1095</Start>
              <Length>11</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/methicillin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6087</Extra>
            </Markup>
            <Markup>
              <Start>1341</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Therapeutic Uses (Complete) data for TRIMETHOPRIM/SULFAMETHOXAZOLE (25 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>105</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/6780#section=Therapeutic-Uses-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>46</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/TRIMETHOPRIM%2FSULFAMETHOXAZOLE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug Warnings</TOCHeading>
      <Description>Drug warnings information collected by the Hazardous Substances Data Bank (HSDB) from various sources, including US Pharmacopeia (USP), physicians desk references, MSDS, etc.</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1056</Reference>
        <Value>
          <StringWithMarkup>
            <String>Trimethoprim-sulfamethoxazole should not be used to treat streptococcal pharyngitis, since it does not eradicate the microorganism.</String>
            <Markup>
              <Start>0</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim-sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Hussar, D.A. (ed.). Modell&apos;s Drugs in Current Use and New Drugs. 38th ed. New York, NY: Springer Publishing Co., 1992., p. 165</Reference>
        <Value>
          <StringWithMarkup>
            <String>Since serious reactions such as the Stevens-Johnson syndrome have occurred in some individuals, therapy should be discontinued at the first appearance of skin rash or other adverse effects.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Hussar, D.A. (ed.). Modell&apos;s Drugs in Current Use and New Drugs. 38th ed. New York, NY: Springer Publishing Co., 1992., p. 165</Reference>
        <Value>
          <StringWithMarkup>
            <String>May increase the action of warfarin and phenytoin.</String>
            <Markup>
              <Start>27</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/warfarin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-54678486</Extra>
            </Markup>
            <Markup>
              <Start>40</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/phenytoin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-1775</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Hussar, D.A. (ed.). Modell&apos;s Drugs in Current Use and New Drugs. 38th ed. New York, NY: Springer Publishing Co., 1992., p. 165</Reference>
        <Value>
          <StringWithMarkup>
            <String>Should not be used in pregnancy at term or during the nursing period.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Drug Warnings (Complete) data for TRIMETHOPRIM/SULFAMETHOXAZOLE (13 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>102</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/6780#section=Drug-Warnings-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>43</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/TRIMETHOPRIM%2FSULFAMETHOXAZOLE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug Idiosyncrasies</TOCHeading>
      <Description>An abnormal individual response to a drug causing an effect quite different from that expected. Idiosyncrasy is inherent in the person concerned and is usually due to a genetic anomaly. It may take the form of hypersensitivity so that the normal effect is produced by a dose which is a small fraction of the standard dose.</Description>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:2596461</Reference>
        <Reference>Alberti-Flor JJ et al; Am J Gastroenterol 84 (12): 1577-9 (1989)</Reference>
        <Value>
          <StringWithMarkup>
            <String>A 26 yr old patient with fulminant liver failure and acute hemorrhagic pancreatitis secondary to the use of trimethoprim-sulfamethoxazole (Bactrim DS) is reported. Patient presented with skin rash and decreased C3 and C4 levels, which was believed to be due to a hypersensitivity reaction secondary to the sulfonamide component (sulfamethoxazole). This is believed to be the first case reported in which sulfamethoxazole-trimethoprim has been implicated as a cause of fulminant liver failure and acut hemorrhagic pancreatitis simultaneously, and emphasizes the need of discontinuing this medication as soon as there is evidence of liver and pancreatic dysfunction.</String>
            <Markup>
              <Start>108</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim-sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>329</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>404</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole-trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:2672812</Reference>
        <Reference>Joffe AM et al; Am J Med 87 (Sep): 332-8 (1989)</Reference>
        <Value>
          <StringWithMarkup>
            <String>Three cases of aseptic meningitis in 3 women, aged 25, 54, and 57 yr, related to the use of trimethoprim in combination with sulfamethoxazole are reported, and a review of the literature relevant to this unusual adverse drug reaction was presented. Two of the patients developed symptoms of meningitis within one day of beginning therapy with trimethoprim-sulfamethoxazzole, while the third patient developed meningitis after receiving 4 doses of trimethoprim-sulfamethoxazzole. One patient was treated with dexamethasone. The 57 yr old woman inadvertently received trimethoprim-sulfamethoxazzole 4 additional times before the combination was identified as the cause of meningitis. Each time symptoms of meningitis recurred.</String>
            <Markup>
              <Start>92</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>125</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>343</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>447</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>508</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/dexamethasone</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5743</Extra>
            </Markup>
            <Markup>
              <Start>566</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug Tolerance</TOCHeading>
      <Description>Drug tolerance refers to the reduced reaction of the body to a drug following its repeated use. Although increasing its dosage may re-amplify the drug&apos;s effects, this may accelerate tolerance, further reducing the drug&apos;s effects.  This section provides information on drug tolerance in humans and other species.</Description>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1055</Reference>
        <Value>
          <StringWithMarkup>
            <String>The frequency of development of bacterial resistance to trimethoprim- sulfamethoxazole is lower than it is to either of the agents alone. This is logical, since a microoganism that has acquired resistance to one of the components may still be killed by the other. Trimethoprim-resistant microorganisms may arise by mutation. Resistance in gram-negative bacteria is often associated with the acquisiton of a plasmid that codes for an altered dihydrofolate reductase. Resistance to trimethoprim in Staphylococcus aureus appears to be determined by a chromosomal gene rather than by a plasmid. The development of resistance to the combination also occurs in vivo. Resistance of Staphylococcus aureus increased from 0.4% to 12.6% during one 5-year period of use. In New York, 10 to 20% of gram-negative microorganisms were found to be resistant.</String>
            <Markup>
              <Start>56</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>70</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>264</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>441</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/dihydrofolate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
            <Markup>
              <Start>480</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Pharmacology and Biochemistry</TOCHeading>
    <Description>Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.</Description>
    <Section>
      <TOCHeading>MeSH Pharmacological Classification</TOCHeading>
      <Description>Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.</Description>
      <URL>https://meshb.nlm.nih.gov/record/ui?ui=D020228</URL>
      <Information>
        <ReferenceNumber>45</ReferenceNumber>
        <Name>Anti-Bacterial Agents</Name>
        <Value>
          <StringWithMarkup>
            <String>Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)</String>
            <Markup>
              <Start>69</Start>
              <Length>49</Length>
              <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&amp;DbFrom=mesh&amp;Cmd=Link&amp;LinkName=mesh_pccompound&amp;IdsFromResult=68000900</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>46</ReferenceNumber>
        <Name>Anti-Infective Agents, Urinary</Name>
        <Value>
          <StringWithMarkup>
            <String>Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)</String>
            <Markup>
              <Start>113</Start>
              <Length>58</Length>
              <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&amp;DbFrom=mesh&amp;Cmd=Link&amp;LinkName=mesh_pccompound&amp;IdsFromResult=68000892</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>47</ReferenceNumber>
        <Name>Antimalarials</Name>
        <Value>
          <StringWithMarkup>
            <String>Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)</String>
            <Markup>
              <Start>224</Start>
              <Length>41</Length>
              <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&amp;DbFrom=mesh&amp;Cmd=Link&amp;LinkName=mesh_pccompound&amp;IdsFromResult=68000962</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Pharmacological Classification</TOCHeading>
      <Description>Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA &quot;Established Pharmacologic Class&quot; (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.</Description>
      <URL>https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
      </DisplayControls>
      <Information>
        <ReferenceNumber>19</ReferenceNumber>
        <Name>Non-Proprietary Name</Name>
        <Value>
          <StringWithMarkup>
            <String>SULFAMETHOXAZOLE AND TRIMETHOPRIM</String>
            <Markup>
              <Start>0</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/SULFAMETHOXAZOLE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>21</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/TRIMETHOPRIM</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>19</ReferenceNumber>
        <Name>Pharmacological Classes</Name>
        <Value>
          <StringWithMarkup>
            <String>Sulfonamide Antimicrobial [EPC]; Dihydrofolate Reductase Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Dihydrofolate Reductase Inhibitor Antibacterial [EPC]; Cytochrome P450 2C8 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; Sulfonamides [CS]</String>
            <Markup>
              <Start>33</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Dihydrofolate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
            <Markup>
              <Start>113</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Dihydrofolate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>ATC Code</TOCHeading>
      <Description>The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.</Description>
      <URL>https://www.whocc.no/atc/structure_and_principles/</URL>
      <Information>
        <ReferenceNumber>24</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>J - Antiinfectives for systemic use</String>
            <Markup>
              <Start>0</Start>
              <Length>1</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=J</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>J01 - Antibacterials for systemic use</String>
            <Markup>
              <Start>0</Start>
              <Length>3</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=J01</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>J01E - Sulfonamides and trimethoprim</String>
            <Markup>
              <Start>0</Start>
              <Length>4</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=J01E</URL>
            </Markup>
            <Markup>
              <Start>24</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>J01EE - Combinations of sulfonamides and trimethoprim, incl. derivatives</String>
            <Markup>
              <Start>0</Start>
              <Length>5</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=J01EE</URL>
            </Markup>
            <Markup>
              <Start>41</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>J01EE01 - Sulfamethoxazole and trimethoprim</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=J01EE01</URL>
            </Markup>
            <Markup>
              <Start>10</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>31</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Absorption, Distribution and Excretion</TOCHeading>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1992 (Plus Supplements 1992)., p. 461</Reference>
        <Value>
          <StringWithMarkup>
            <String>Co-trimoxazole is widely distributed into body tissues and fluids, including sputum, aqueous humor, middle ear fluid, prostatic fluid, vaginal fluid, bile, and cerebrospinal fluid; trimethoprim also distributes into bronchial secretions. Trimethoprim has a larger volume of distribution than does sulfamethoxazole. In adults, apparent volume of distribution of 100-120 and 12-18 l have been reported for trimethoprim and sulfamethoxazole, respectively. In patients with uninflamed meninges, trimethoprim and sulfamethoxazole concentrations in cerebrospinal fluid are about 50 and 40%, respectively, of concurrent serum concentrations of the drugs. Trimethoprim and sulfamethoxazole concentrations in middle ear fluid are approximately 75 and 20%, respectively, and in prostatic fluid are approximately 200 and 35%, respectively, of concurrent serum concentrations of the drugs.</String>
            <Markup>
              <Start>0</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Co-trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>181</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>238</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>297</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>404</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>421</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>491</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>508</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>648</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>665</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1055</Reference>
        <Value>
          <StringWithMarkup>
            <String>After a single oral dose of the combined preparation, trimethoprim is absorbed more rapidly than sulfamethoxazole. The concurrent administration of the drugs appears to slow the absorption of sulfamethoxazole. Peak blood concentrations of trimethoprim ususally occur by 2 hours in most patients, while peak concentrations of sulfamethoxazole occur by 4 hours after a single oral dose.</String>
            <Markup>
              <Start>54</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>97</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>192</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>239</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>325</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1055</Reference>
        <Value>
          <StringWithMarkup>
            <String>Trimethoprim is rapidly distributed and concentrated in tissues, and about 40% is bound to plasma protein in the presence of sulfamethoxazole. The volume of distribution of trimethoprim is almost nine times that of sulfamethoxazole. The drug readily enters cerebrospinal fluid and sputum. High concentrations of each component of the mixture are also found in bile.</String>
            <Markup>
              <Start>0</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>125</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>173</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>215</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Stevens RC et al; Antimicrob Agents Chemother 35 (9): 1991 1884-90 (1990)</Reference>
        <Value>
          <StringWithMarkup>
            <String>The pharmacokinetics of trimethoprim-sulfamethoxazole were studied in 12 healthy adult subjects receiving trimethoprim at 20 mg/kg of body weight per day and sulfamethoxazole at 100 mg/kg/day, which is the conventional dose for treating Pneumocystis carinii pneumonia. Daily doses were evenly divided and orally administered every 6 h for 3 days. Trimethoprim, sulfamethoxazole, and N4-acetylsulfamethoxazole concn in serum and urine were measured by HPLC. Five subjects withdrew from the study because of intolerable GI and CNS toxicities. In the seven subjects that completed the study, the mean maximum serum drug concn after the last dose were 13.6 + or - 2.0, 372 + or - 64, and 50.1 + or - 10.9 ug/ml for trimethoprim, sulfamethoxazole, and N4-acetylsulfamethoxazole, respectively. The mean half-lives were 13.6 + or - 3.5, 14.0 + or - 2.3, and 18.6 + or - 4.3 hr, respectively. Changes in absolute neutrophil count were significantly correlated with the minimum concn of trimethoprim and sulfamethoxazole in serum and trimethoprim area under the concn-time curve (for all three parameters, r2 = 0.6 and p &lt; 0.05). These findings add to the evidence that serum drug concn in adults following the conventional dose of trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia are excessive and contribute to certain adverse reactions.</String>
            <Markup>
              <Start>24</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim-sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>106</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>158</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>347</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>361</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>383</Start>
              <Length>25</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/N4-acetylsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-65280</Extra>
            </Markup>
            <Markup>
              <Start>711</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>725</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>747</Start>
              <Length>25</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/N4-acetylsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-65280</Extra>
            </Markup>
            <Markup>
              <Start>978</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>995</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>1025</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:2678767</Reference>
        <Reference>Paap CM, Nahata MC; DICP 23 (9): 646-54 (1989)</Reference>
        <Value>
          <StringWithMarkup>
            <String>This article reviews the pharmacokinetics, clinical use, and adverse effects of trimethoprim/sulfamethoxazole in renally impaired patients. Renal dysfunction changes the pharmacokinetics of both component drugs. Trimethoprim and sulfamethoxazole disposition are not significantly altered until creatinine clearance is less than 30 ml/min, when sulfamethoxazole metabolites and trimethoprim accumulate and may lead to toxicity. Renal dysfunction, however, does not preclude the use of trimethoprim/sulfamethoxazole to treat susceptible infections, even when creatinine clearance is less than 15 ml/min. Adverse effects may occur more frequently in renally impaired patients but are not clearly related to increased serum concentrations of either drug. Guidelines for appropriate dosing and monitoring of trimethoprim/sulfamethoxazole therapy in these patients are presented.</String>
            <Markup>
              <Start>80</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>212</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>229</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>294</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/creatinine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-588</Extra>
            </Markup>
            <Markup>
              <Start>344</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>377</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>484</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>557</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/creatinine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-588</Extra>
            </Markup>
            <Markup>
              <Start>803</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Metabolism/Metabolites</TOCHeading>
      <Description>Metabolites are substances made or used when the body breaks down food, drugs or chemicals, or its own tissue (for example, fat or muscle tissue). This process is called metabolism and makes energy and the materials needed for growth, reproduction, and maintaining health. Metabolism also helps get rid of toxic substances.</Description>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1992 (Plus Supplements 1992)., p. 461</Reference>
        <Value>
          <StringWithMarkup>
            <String>Co-trimoxazole is metabolized in the liver. Trimethoprim is metabolized to oxide and hydroxylated metabolites and sulfamethoxazole is principally N-acetylated and also conjugated with glucuronic acid. Both drugs are rapidly excreted in urine via glomerular filtration and tubular secretion. In adults with normal renal function, approximately 50-60% of a trimethoprim and 45-70% of a sulfamethoxazole oral dose are excreted in urine within 24 hours. Approximately 80% of the amount of trimethoprim and 20% of the amount of sulfamethoxazole recovered in urine are unchanged drug. In adults with normal renal function, urinary concentrations of active trimethoprim are approximately equal to those of active sulfamethoxazole. Urinary concentrations of both active drugs are decreased in patients with impaired renal function.</String>
            <Markup>
              <Start>0</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Co-trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>44</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>114</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>184</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/glucuronic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-94715</Extra>
            </Markup>
            <Markup>
              <Start>355</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>384</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>485</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>523</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>650</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>706</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Biological Half-Life</TOCHeading>
      <Description>The time required for a biological system (e.g., human body) to eliminate, by natural processes, half of the amount of a chemical (e.g., alcohol, medication, or radioactive material) that has entered it.</Description>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1055</Reference>
        <Value>
          <StringWithMarkup>
            <String>The half-lives of trimethoprim and sulfamethoxazole are approximately 11 and 10 hours, respectively.</String>
            <Markup>
              <Start>18</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>35</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Mechanism of Action</TOCHeading>
      <Description>In medicine, the term &quot;mechanism of action&quot; (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug&apos;s mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.</Description>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1343</Reference>
        <Value>
          <StringWithMarkup>
            <String>Trimethoprim/sulfamethoxazole ... inhibits sequential steps in the synthesis of tetrahydrofolic acid, an essential metabolic cofactor in the bacterial synthesis of purines, thymidine, glycine, and methionine. Sulfonamides, including sulfamethoxazole, are structural analogues of para-aminobenzoic acid and block the synthesis of dihydropteroic acid, the immediate precursor of dihydrofolic acid, from para-aminobenzoic acid and peridine. Trimethoprim subsequently acts to inhibit the reduction of dihydrofolic acid to the metabolically active tetrahydrofolic acid by the enzyme, dihydrofolate reductase. The most important consequence of this sequential enzymatic inhibition appears to be the interruption of thymidine synthesis.</String>
            <Markup>
              <Start>0</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>80</Start>
              <Length>20</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/tetrahydrofolic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135444742</Extra>
            </Markup>
            <Markup>
              <Start>173</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/thymidine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5789</Extra>
            </Markup>
            <Markup>
              <Start>184</Start>
              <Length>7</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/glycine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-750</Extra>
            </Markup>
            <Markup>
              <Start>197</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/methionine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6137</Extra>
            </Markup>
            <Markup>
              <Start>233</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>279</Start>
              <Length>22</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/para-aminobenzoic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-978</Extra>
            </Markup>
            <Markup>
              <Start>329</Start>
              <Length>19</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/dihydropteroic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398662</Extra>
            </Markup>
            <Markup>
              <Start>377</Start>
              <Length>17</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/dihydrofolic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
            <Markup>
              <Start>401</Start>
              <Length>22</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/para-aminobenzoic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-978</Extra>
            </Markup>
            <Markup>
              <Start>438</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>497</Start>
              <Length>17</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/dihydrofolic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
            <Markup>
              <Start>543</Start>
              <Length>20</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/tetrahydrofolic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135444742</Extra>
            </Markup>
            <Markup>
              <Start>579</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/dihydrofolate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398604</Extra>
            </Markup>
            <Markup>
              <Start>709</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/thymidine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5789</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1054</Reference>
        <Value>
          <StringWithMarkup>
            <String>The synergistic interaction between sulfonamide and trimethoprim is thus predictable from their respective mechanisms. There is an optimal ratio of the concentrations of the two agents for synergism, and this is equal to the ratio of the minimal inhibitory concentrations of the drugs acting independently. While this ratio varies for different bacteria, the most effective ratio for the greatest number of microorganisms is 20 parts of sulfamethoxazole to one part of trimethoprim. The combination is formulated to achieve a sulfamethoxazole concentration in vivo 20 times greater than that of trimethoprim. ... The pharmacokinetic properties of the sulfonamide chosen to be in combination with trimethoprim are important, since relative constancy of the concentrations of the two compounds in the body is desired.</String>
            <Markup>
              <Start>52</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>437</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>469</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>526</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>595</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>696</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1344</Reference>
        <Value>
          <StringWithMarkup>
            <String>Trimethoprim/sulfamethoxazole is active in vitro against a variety of gram-negative and gram-postive bacteria. Among aerobic gram-negative enteric bacteria, Escherichia coli, Proteus mirabilis, Salmonella (including Salmonella typhi), Shigella, and Citrobacter are very susceptible. Indole-positive Proteus, Serratia marcescens, Klebsiella pneumoniae, Enterobacter, Providencia stuartii are moderately susceptible.</String>
            <Markup>
              <Start>0</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim%2Fsulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>283</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Indole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-798</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:3237218</Reference>
        <Reference>Harle DG et al; Mol Immunol 25 (12): 1347-54 (1988)</Reference>
        <Value>
          <StringWithMarkup>
            <String>An immunoassay was developed for the detection of sulfamethoxazole reactive IgE antibodies in the sera of patients who experienced life threatening anaphylactic reactions following the ingestion of co-trimoxazole (trimethoprim and sulfamethoxazole). Patients who had significant levels of sulfamethoxazole reactive IgE antibodies in their sera did not have IgE antibodies that reacted with trimethoprim-Sepharose. Inhibition experiments with a number of sulfonamides to determine the fine structural specificities of the sulfamethoxazole reactive IgE antibodies in three patients revealed that sulfamethoxazole and, depending on the serum, sulfamerazine and sulfamethizole, were the most potent inhibitors of IgE binding, whereas the parent sulfonamide, sulfanilamide, was a very poor inhibitor. From a detailed examination of structure-activity relationships, we concluded that the 5-methyl-3-isoxazolyl group on the sulfamethoxazole molecule was the allergenic determinant for all three patients with the 5-methyl group being particularly important for IgE antibody recognition. The assays for the detection of IgE antibodies to sulfamethoxazole and trimethoprim should prove useful for the diagnosis of immediate hypersensitivity to co-trimoxazole and perhaps for monitoring drug therapy in AIDS patients where a high incidence of adverse reactions to co-trimoxazole has been reported.</String>
            <Markup>
              <Start>50</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>198</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/co-trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>214</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>231</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>289</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>390</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>403</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sepharose</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-11966311</Extra>
            </Markup>
            <Markup>
              <Start>521</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>594</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>640</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamerazine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5325</Extra>
            </Markup>
            <Markup>
              <Start>658</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethizole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5328</Extra>
            </Markup>
            <Markup>
              <Start>754</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfanilamide</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5333</Extra>
            </Markup>
            <Markup>
              <Start>918</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>1131</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>1152</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>1236</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/co-trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
            <Markup>
              <Start>1355</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/co-trimoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-358641</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Use and Manufacturing</TOCHeading>
    <Description>This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.</Description>
    <Section>
      <TOCHeading>Uses</TOCHeading>
      <Description>Major uses of this chemical, including both consumer uses and industrial uses.</Description>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>QC REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>MEDICATION</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Section>
        <TOCHeading>Use Classification</TOCHeading>
        <Description>This section contains use classification/category information for this compound from various sources.</Description>
        <Information>
          <ReferenceNumber>15</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Human Drugs -&gt; FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -&gt; Active Ingredients</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Formulations/Preparations</TOCHeading>
      <Description>Information on Formulations/Preparations of this chemical, collected by the Hazardous Substances Data Bank (HSDB) from various sources.</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Reynolds, J.E.F., Prasad, A.B. (eds.) Martindale-The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982., p. 1460</Reference>
        <Value>
          <StringWithMarkup>
            <String>A mixture of 5 parts of sulfamethoxazole and 1 part trimethoprim.</String>
            <Markup>
              <Start>24</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>52</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Identification</TOCHeading>
    <Description>This section contains laboratory methods used to identify this chemical.</Description>
    <Section>
      <TOCHeading>Analytic Laboratory Methods</TOCHeading>
      <Description>Analytic laboratory methods for analyzing this compound in a sample. The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.</Description>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Association of Official Analytical Chemists. Official Methods of Analysis. 15th ed. and Supplements. Washington, DC: Association of Analytical Chemists, 1990, p. V1 15/569</Reference>
        <Value>
          <StringWithMarkup>
            <String>Sulfamethoxazole content of drug tablets, solutions, and ointments is determined by reverse phase LC using tenary aqueous mobile phase, UV detection at 254 nm, and sulfadimethoxine as internal standard.</String>
            <Markup>
              <Start>0</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
            <Markup>
              <Start>164</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfadimethoxine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5323</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>HELBOE P, THOMSEN H; ARCH PHARM CHEM SCI ED 5 (2): 25-32 (1977)</Reference>
        <Value>
          <StringWithMarkup>
            <String>HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF TRIMETHOPRIM &amp; SULFONAMIDE COMBINATION IN PHARMACEUTICALS; SPECTROPHOTOMETRY AT 230 NM.</String>
            <Markup>
              <Start>57</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/TRIMETHOPRIM</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Clinical Laboratory Methods</TOCHeading>
      <Description>Clinical laboratory methods for detecting, isolating, separating, and/or analyzing this compound in a sample.  The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.</Description>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Stevens RC et al; Antimicrob Agents Chemother 35 (9): 1991 1884-90 (1990)</Reference>
        <Value>
          <StringWithMarkup>
            <String>Trimethoprim and sulfamethoxazole concn in serum and urine are measured by HPLC.</String>
            <Markup>
              <Start>0</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5578</Extra>
            </Markup>
            <Markup>
              <Start>17</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>16</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:1747405</Reference>
        <Reference>Avgerinos A et al; J Pharm Biomed Anal 9 (6): 507-10 (1991)</Reference>
        <Value>
          <StringWithMarkup>
            <String>A simple and rapid method is developed for the analysis of sulfamethoxazole in human plasma and urine by HPLC. It involves minimal sample preparation and single wavelength monitoring. The detection limit of the method is 0.1 ug/ml, and covers the entire concn range normally encountered therapeutically.</String>
            <Markup>
              <Start>59</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5329</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Safety and Hazards</TOCHeading>
    <Description>Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.</Description>
    <Section>
      <TOCHeading>Handling and Storage</TOCHeading>
      <Description>This section provides guidance on the safe handling practices and storage conditions for this chemical.  The information in this section includes precautions for safe handling, such as recommendations for handling incompatible chemicals, minimizing the release of the chemical into the environment, and providing advice on general hygiene practices (e.g., eating, drinking, and smoking in work areas is prohibited).  In addition, this section provides recommendations on the conditions for safe storage (including any incompatibilities) as well as advice on specific storage requirements (e.g., ventilation requirements).  </Description>
      <URL>https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf</URL>
      <Section>
        <TOCHeading>Storage Conditions</TOCHeading>
        <Description>Conditions for safe storage of this compound, including any incompatible chemicals and specific storage requirements (e.g., ventilation requirements).</Description>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1992 (Plus Supplements 1992)., p. 460</Reference>
          <Value>
            <StringWithMarkup>
              <String>Co-trimoxazole concentrate for injection should be stored at 15-30 Â°C and should not be refrigerated. Oral suspensions of the drug should be stored in tight, light resistant containers at 15-25 or 15-30 Â°C, depending on the formulation (the manufacturer&apos;s recommendations should be followed), and the tablets should be stored in well-closed, light-resistant containers at 15-30 Â°C.</String>
              <Markup>
                <Start>0</Start>
                <Length>14</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Co-trimoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Regulatory Information</TOCHeading>
      <Description>This section lists the safety, health, and environmental regulations concerning the chemical and products containing it.  The information may include any national and/or regional regulatory information of the chemical or mixtures.</Description>
      <Section>
        <TOCHeading>FDA Requirements</TOCHeading>
        <Description>FDA requirements regarding this chemical and products containing it.  FDA Requirements means any requirements of the Federal Food, Drug and Cosmetic Act (FDCA), as amended, and any rules or regulations promulgated thereunder which are or may be applicable to the manufacture, sale, labeling or distribution of the products regulated by FDA (e.g., drugs, biologics, dietary supplements, foods, cosmetics, tobacco products, etc.).</Description>
        <URL>https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act</URL>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>21 CFR 200-299, 300-499, 820, and 860 (4/1/91</Reference>
          <Value>
            <StringWithMarkup>
              <String>Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Toxicity</TOCHeading>
    <Description>Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.</Description>
    <Section>
      <TOCHeading>Toxicological Information</TOCHeading>
      <Description>This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.</Description>
      <Section>
        <TOCHeading>Effects During Pregnancy and Lactation</TOCHeading>
        <Description>Drug effects during pregnancy and lactation.</Description>
        <Information>
          <ReferenceNumber>10</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>â Summary of Use during Lactation</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>With healthy, fullterm infants it appears acceptable to use sulfamethoxazole and trimethoprim during breastfeeding after the newborn period. The time of greatest risk for hemolysis in fullterm newborns without glucose-6-phosphate dehydrogenase (G6PD) deficiency might be as short as 8 days after birth. Until further data are accumulated, alternate agents should probably be used in jaundiced, ill, stressed or premature infants, because of the risk of bilirubin displacement and kernicterus. Sulfamethoxazole and trimethoprim should be avoided while breastfeeding a G6PD-deficient infant.</String>
              <Markup>
                <Start>60</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>81</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>210</Start>
                <Length>19</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/glucose-6-phosphate</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5958</Extra>
              </Markup>
              <Markup>
                <Start>453</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/bilirubin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5280352</Extra>
              </Markup>
              <Markup>
                <Start>493</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>514</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â Effects in Breastfed Infants</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>An extensive systematic review of the use of sulfonamides near term and during breastfeeding found no adverse reactions in infants. The authors concluded that use of sulfamethoxazole-trimethoprim during breastfeeding presents no risk of neonatal kernicterus.</String>
              <Markup>
                <Start>166</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole-trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>A prospective, controlled study asked mothers who called an information service about adverse reactions experience by their breastfed infants. Of 12 women who took sulfamethoxazole and trimethoprim during breastfeeding (time postpartum and dosage not stated), none reported diarrhea, drowsiness or irritability in her infant. Two mothers reported poor feeding in their infants.</String>
              <Markup>
                <Start>164</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>185</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â Effects on Lactation and Breastmilk</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Relevant published information was not found as of the revision date.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>18</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>â What is sulfamethoxazole and trimethoprim?</String>
              <Markup>
                <Start>10</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>31</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole and trimethoprim are medications that are used to treat bacterial infections. These two medications are usually given together and sold under the brand names BactrimÂ® or SeptraÂ®. The combination of these antibiotics is used to treat a variety of infections, including urinary tract infections (UTIs).</String>
              <Markup>
                <Start>0</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>21</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â I take sulfamethoxazole/trimethoprim. Can it make it harder for me to get pregnant?</String>
              <Markup>
                <Start>9</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>26</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>It is not known if sulfamethoxazole/trimethoprim can make it harder to get pregnant.</String>
              <Markup>
                <Start>19</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>36</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â I just found out I am pregnant. Should I stop taking sulfamethoxazole/trimethoprim?</String>
              <Markup>
                <Start>55</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>72</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Talk with your healthcare providers before making any changes to how you take your medication. The benefits of taking your medication may outweigh the risks of untreated illness. It is important to treat most infections during pregnancy. Untreated UTIs could lead to severe kidney infection for the person who is pregnant, preterm delivery (delivery before 37 weeks of pregnancy) and preeclampsia (dangerously high blood pressure).</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â I am taking sulfamethoxazole/trimethoprim, but I would like to stop taking it before becoming pregnant. How long do these medications stay in my body?</String>
              <Markup>
                <Start>14</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>31</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>People eliminate medication at different rates. In healthy adults, it takes up to 3 days, on average, for most of sulfamethoxazole/trimethoprim to be gone from the body.</String>
              <Markup>
                <Start>114</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>131</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â Does taking sulfamethoxazole/trimethoprim increase the chance for miscarriage?</String>
              <Markup>
                <Start>14</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>31</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Miscarriage can occur in any pregnancy. Two studies have found an association with the use of sulfamethoxazole/trimethoprim in the first trimester and with miscarriage. However, one of these studies did not consider other factors that may have contributed to the chance of miscarriage.</String>
              <Markup>
                <Start>94</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>111</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â Does taking sulfamethoxazole/trimethoprim increase the chance of birth defects?</String>
              <Markup>
                <Start>14</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>31</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. There are not many well controlled studies on the use of sulfamethoxazole only in human pregnancy. Sulfamethoxazole is part of a group of medications called sulfonamides. Some studies have suggested the use of sulfonamides during the first trimester may be associated with an increased chance for birth defects while other studies have not.Concern has also been raised with the use of trimethoprim in pregnancy. There have been studies involving several hundred individuals using this medication at any time in pregnancy. Some studies have not found an increased chance for birth defects. However, a few studies looking at trimethoprim used with a sulfonamide during the first trimester have found an increased chance for birth defects, including heart defects, neural tube defects (opening in the spine), cleft lip or palate, and urinary tract defects.Trimethoprim may lower the level of folic acid in your body. Folic acid is a B vitamin that helps the body make new healthy cells and may help reduce the chance of certain birth defects, like spina bifida, in the baby. It is recommended that people who are pregnant or planning a pregnancy consume between 400-800 micrograms of folic acid each day from foods or vitamin supplements. If sulfamethoxazole/trimethoprim is taken during the first trimester, your healthcare provider may suggest that you take more folic acid. You can talk with them about how much folic acid is right for you.Use of sulfamethoxazole and trimethoprim after the first trimester is not associated with a higher chance of birth defects in the baby. Overall, if there is an increased chance for birth defects with use of sulfamethoxazole/trimethoprim during pregnancy, it appears to be small.</String>
              <Markup>
                <Start>165</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>207</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>493</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>731</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>961</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>997</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folic%20acid</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
              <Markup>
                <Start>1022</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Folic%20acid</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
              <Markup>
                <Start>1289</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folic%20acid</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
              <Markup>
                <Start>1347</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>1364</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>1470</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folic%20acid</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
              <Markup>
                <Start>1520</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folic%20acid</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
              <Markup>
                <Start>1555</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>1576</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>1755</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>1772</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â Could taking sulfamethoxazole/trimethoprim cause other pregnancy complications?</String>
              <Markup>
                <Start>15</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>32</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>One study has suggested that individuals who take medications that may lower levels of folic acid are at a greater chance for pregnancy complications such as preeclampsia, placenta abruption (when the placenta breaks away from the wall of the uterus) and fetal growth restriction. Exposure to sulfamethoxazole/trimethoprim has been associated with preterm delivery and low birth weight. However, this medication is frequently used to treat UTIs, and people who are pregnant with UTIs are at a greater chance for some of the same complications. It is hard to determine whether it is the medication, the decrease in folic acid, the underlying infection, or other factors which are increasing the chance for these complications.</String>
              <Markup>
                <Start>87</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folic%20acid</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
              <Markup>
                <Start>293</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>310</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>614</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folic%20acid</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â Can I take sulfamethoxazole/trimethoprim in the 3rd trimester?</String>
              <Markup>
                <Start>13</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>30</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Some authors have recommended not taking sulfonamides such as sulfamethoxazole after 32 weeks of pregnancy. There is a theoretical concern that sulfonamide use near the end of pregnancy can increase the chance for severe jaundice (a problem with liver function) and related complications in the baby. Your healthcare provider can help to suggest a medication that is right for you.</String>
              <Markup>
                <Start>62</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â Does taking sulfamethoxazole/trimethoprim in pregnancy cause long-term problems in behavior or learning for the baby?</String>
              <Markup>
                <Start>14</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>31</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>It is not known if sulfamethoxazole/trimethoprim can cause behavior or learning issues.</String>
              <Markup>
                <Start>19</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>36</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â Can I breastfeed while taking sulfamethoxazole/trimethoprim ?</String>
              <Markup>
                <Start>32</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>49</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sulfamethoxazole and trimethoprim pass into breast milk in small amounts. There is some concern about taking sulfamethoxazole and trimethoprim while breastfeeding if the baby is born before 37 weeks of pregnancy, has severe jaundice, or a condition known as glucose-6- phosphate dehydrogenase deficiency (G6PD deficiency). However, it is not always necessary to stop breastfeeding while taking these medications. Be sure to talk to your healthcare provider about all your breastfeeding questions.</String>
              <Markup>
                <Start>0</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>21</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>109</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>130</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>258</Start>
                <Length>20</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/glucose-6-phosphate</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5958</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>â I take sulfamethoxazole/trimethoprim. Can it make it harder for me to get my partner pregnant or increase the chance of birth defects?</String>
              <Markup>
                <Start>9</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>26</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>The combination of sulfamethoxazole and trimethoprim was found to lower sperm production in males who were taking it continuously for one month. A lowered sperm count may affect the ability to conceive a pregnancy.There are no studies looking at chance for birth defects when the father or sperm donor takes sulfamethoxazole/trimethoprim. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures at https://mothertobaby.org/fact-sheets/paternal-exposures-pregnancy/.</String>
              <Markup>
                <Start>19</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>40</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>308</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>325</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Acute Effects</TOCHeading>
        <Description>The results from acute animal tests and/or acute human studies are presented in this section. Acute animal studies consist of LD50 and LC50 tests, which present the median lethal dose (or concentration) to the animals. Acute human studies usually consist of case reports from accidental poisonings or industrial accidents. These case reports often help to define the levels at which acute toxic effects are seen in humans.</Description>
        <Information>
          <ReferenceNumber>5</ReferenceNumber>
          <Value>
            <ExternalTableName>chemidplus</ExternalTableName>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Interactions</TOCHeading>
        <Description>Interactions of this compound with other chemicals, according to the Hazardous Substances Data Bank (HSDB).</Description>
        <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1723</Reference>
          <Value>
            <StringWithMarkup>
              <String>Concomitant administration of trimethoprim or trimethoprim/sulfamethoxazole with methotrexate may increase bone marrow suppression, probably as an additive antifolate effect.</String>
              <Markup>
                <Start>30</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>46</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
              <Markup>
                <Start>81</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/methotrexate</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-126941</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>/Oral/ antidiabetic agents, may be displaced from protein binding sites and/or their metabolism may be inhibited by some sulfonamides, resulting in increased or prolonged effects and/or toxicity; dosage adjustments may be necessary during and after sulfonamide therapy. /Sulfonamides/</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Concurrent use of bone marrow depressants with sulfonamides may increase the leukopenic and/or thrombocytopenic effects; if concurrent use is required, close observation for myelotoxic effects should be considered. /Sulfonamides/</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Concurrent long-term use of sulfonamides /and estrogen-containing oral contraceptives/ may result in reduced contraceptive reliability and increased incidence of breakthrough bleeding. /Sulfonamides/</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Value>
            <StringWithMarkup>
              <String>For more Interactions (Complete) data for TRIMETHOPRIM/SULFAMETHOXAZOLE (21 total), please visit the HSDB record page.</String>
              <Markup>
                <Start>101</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/6780#section=Interactions-(Complete)</URL>
              </Markup>
              <Markup>
                <Start>42</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/TRIMETHOPRIM%2FSULFAMETHOXAZOLE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Human Toxicity Excerpts</TOCHeading>
        <Description>Excerpts about human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.</Description>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1347</Reference>
          <Value>
            <StringWithMarkup>
              <String>A high incidence (up to 80%) of adverse reactions to trimethoprim/sulfamethoxazole occurs in AIDS patients receiving this combination for the treatment or prophylaxis of Pneumocystis carinii pneumonia. These adverse reactions have included nausea and vomiting, fever, cutaneous reactions (erythroderma, morbilliform rash, toxic epidermal necrolysis, Stevens-Johnson syndrome), peripheral cytopenias (neutropenia, thrombocytopenia, anemia), hepatitis, and azotemia. Some of these are believed to be hypersensitivity reactions because they recur with drug rechallenge. However, some of the serious toxic reactions associated with trimethoprim/sulfamethoxazole, such as myelosuppression, appear to be dose related. Concomitant zidovudine may exacerbate the myelosusppression.</String>
              <Markup>
                <Start>53</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
              <Markup>
                <Start>628</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
              <Markup>
                <Start>724</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/zidovudine</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-35370</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 1347</Reference>
          <Value>
            <StringWithMarkup>
              <String>Skin rashes are among the most common adverse effects caused by trimethoprim/sulfamethoxazole and are most often due to hypersensitivity to the sulfonamide component. These are usually mild, diffuse, maculopapular rashes that are reversible upon discontinuation of the drug. Serious skin reactions, including toxic epidermal necrolysis, erythema multitome, exfoliative dermatitis, and the Stevens-Johnson syndrome, have occurred rarely.</String>
              <Markup>
                <Start>64</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim%2Fsulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1055</Reference>
          <Value>
            <StringWithMarkup>
              <String>There is no evidence that trimethoprim-sulfamethoxazole, when given in the recommended doses, induces folate deficiency in normal persons. However, the margin between toxicity for bacteria and that for man may be relatively narrow when the cells of the patient are deficient in folate. In such cases, trimethoprim-sulfamethoxazole may cause or precipitate megaloblastosis, leukopenia, or thrombocytopenia. In routine use, the combination appears to exert little toxicity. About 75% of the untoward effects involve the skin. These are typical of those known to be produced by sulfonamides. However, trimethoprim-sulfamethoxazole has been reported to cause up to three times as many dermatological reactions as does sulfisoxazole when given alone.</String>
              <Markup>
                <Start>26</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim-sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
              <Markup>
                <Start>102</Start>
                <Length>6</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folate</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
              <Markup>
                <Start>278</Start>
                <Length>6</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/folate</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-135398658</Extra>
              </Markup>
              <Markup>
                <Start>301</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim-sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
              <Markup>
                <Start>598</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim-sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
              <Markup>
                <Start>714</Start>
                <Length>13</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfisoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5344</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1055</Reference>
          <Value>
            <StringWithMarkup>
              <String>Patients with AIDS frequently react adversely when trimethoprim-sulfamethoxazole is administered to treat infection due to Pneumocystis carinii. Fever, malaise, rash, and/or pancytopenia were noted in 8 of 18 patients in one series; the incidence was 90% in another. It may be possible to continue therapy if the dose of the combination is lowered and concentrations of trimethoprim in plasma are monitored. Renal allograft recipients may suffer from severe hematological toxicity.</String>
              <Markup>
                <Start>51</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim-sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
              <Markup>
                <Start>370</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Value>
            <StringWithMarkup>
              <String>For more Human Toxicity Excerpts (Complete) data for TRIMETHOPRIM/SULFAMETHOXAZOLE (13 total), please visit the HSDB record page.</String>
              <Markup>
                <Start>112</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/6780#section=Human-Toxicity-Excerpts-(Complete)</URL>
              </Markup>
              <Markup>
                <Start>53</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/TRIMETHOPRIM%2FSULFAMETHOXAZOLE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-358641</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Non-Human Toxicity Excerpts</TOCHeading>
        <Description>Excerpts about non-human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.</Description>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Ellenhorn, M.J. and D.G. Barceloux. Medical Toxicology - Diagnosis and Treatment of Human Poisoning. New York, NY: Elsevier Science Publishing Co., Inc. 1988., p. 149</Reference>
          <Value>
            <StringWithMarkup>
              <String>Teratogenic in rats. /From table/</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Studies in rabbits given doses of 150 to 350 mg of sulfamethoxazole causes increased maternal mortality but has no adverse effects on the fetus. Studies in rabbits given doses of trimethoprim 6 times the usual human therapeutic dose have shown that trimethoprim causes an increase in the number of dead, resorbed, and malformed fetuses.</String>
              <Markup>
                <Start>51</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>179</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>249</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Studies in rats given oral doses of 200 mg of trimethoprim and 533 mg of sulfamethoxazole per kg of body weight have shown that sulfamethoxazole causes teratogenic effects (primarily cleft palates). However, doses of 192 mg of trimethoprim per kg of body weight and 512 mg of sulfamethoxazole per kg of body weight, when administered separately, did not cause cleft palates in rats. Doses of 88 mg of trimethoprim per kg of body weight and 355 mg of sulfamethoxazole per kg of body weight have been shown to causes cleft palates when administered concurrently.</String>
              <Markup>
                <Start>46</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>73</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>128</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>227</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>276</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>401</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>450</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Studies in rats, given oral doses as high as 70 mg of trimethoprim per kg of body weight and 350 mg of sulfamethoxazole per kg of body weight daily, have not shown that sulfamethoxazole or trimethoprim causes any adverse effects on fertility or general reproductive performance.</String>
              <Markup>
                <Start>54</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>103</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>169</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>189</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Bacterial mutagenicity studies with sulfamethoxazole and trimethoprim combination have not been done. Trimethoprim has not been shown to be mutagenic in the Ames assay.</String>
              <Markup>
                <Start>36</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulfamethoxazole</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5329</Extra>
              </Markup>
              <Markup>
                <Start>57</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
              <Markup>
                <Start>102</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Trimethoprim</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5578</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Non-Human Toxicity Values</TOCHeading>
        <Description>Quantitative non-human toxicity values (e.g., lethal dose) for this compound.  The data shown here are mostly for lab animals (e.g., rat, mouse, guinea pig, and rabbit).</Description>
        <DisplayControls>
          <ShowAtMost>5</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Budavari, S. (ed.). The Merck Index - Encyclopedia of Chemicals, Drugs and Biologicals. Rahway, NJ: Merck and Co., Inc., 1989., p. 1407</Reference>
          <Value>
            <StringWithMarkup>
              <String>LD50 Mouse oral 5513 mg/kg</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Ecological Information</TOCHeading>
      <Description>This section provides information to evaluate the environmental impact of the chemical if it were released to the environment. The information may include data from toxicity tests performed on aquatic and/or terrestrial organisms, where available (e.g., acute or chronic aquatic toxicity data for fish, algae, and crustaceans; toxicity data on birds, bees, and plants).  This section also includes information on whether there is a potential for the chemical to persist or degrade in the environment either through biodegradation or other processes (such as oxidation or hydrolysis) as well as the concentration or amount of the chemical found in the environment (e.g., in plants, animals as well as in the atmosphere or water).</Description>
      <Section>
        <TOCHeading>Milk Concentrations</TOCHeading>
        <Description>Concentrations of this compound in milk.</Description>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Sulfonamides and trimethoporim are excreted in breast milk.</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Body Burden</TOCHeading>
        <Description>Total amount of a chemical present in an organism at a given time.</Description>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.IB p.2522 (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Sulfonamides and trimethoporim are excreted in breast milk.</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Associated Disorders and Diseases</TOCHeading>
    <Description>Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).</Description>
    <DisplayControls>
      <CreateTable>
        <FromInformationIn>Subsections</FromInformationIn>
        <NumberOfColumns>2</NumberOfColumns>
        <ColumnHeadings>Disease</ColumnHeadings>
        <ColumnHeadings>References</ColumnHeadings>
        <ColumnContents>Name</ColumnContents>
        <ColumnContents>Value</ColumnContents>
      </CreateTable>
    </DisplayControls>
    <Information>
      <ReferenceNumber>7</ReferenceNumber>
      <Value>
        <ExternalTableName>ctd_chemical_disease</ExternalTableName>
      </Value>
    </Information>
    <Information>
      <ReferenceNumber>23</ReferenceNumber>
      <Value>
        <ExternalTableName>collection=ttd_dd</ExternalTableName>
      </Value>
    </Information>
  </Section>
  <Section>
    <TOCHeading>Literature</TOCHeading>
    <Description>Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/docs/literature</URL>
    <Section>
      <TOCHeading>Consolidated References</TOCHeading>
      <Description>The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/docs/literature</URL>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <ExternalTableName>literature</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Coronavirus Studies</TOCHeading>
      <Description>Literature references about coronavirus, aggregated from multiple sources, including PubMed, Protein Data Bank (PDB), DrugBank, and IUPHAR/BPS Guide to PHARMACOLOGY, Springer Nature, and ClinicalTrials.gov.  For clinical studies on coronavirus, see the Clinical Trials section.</Description>
      <Information>
        <ReferenceNumber>21</ReferenceNumber>
        <Value>
          <ExternalTableName>literature_coronavirus</ExternalTableName>
          <ExternalTableNumRows>43</ExternalTableNumRows>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>NLM Curated PubMed Citations</TOCHeading>
      <Description>The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.</Description>
      <URL>https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6</URL>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&amp;db=pccompound&amp;cmd=Link&amp;from_uid=358641</URL>
        <Value>
          <Boolean>true</Boolean>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Springer Nature References</TOCHeading>
      <Description>Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren&apos;t withheld as they might contain also very useful information.</Description>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <ExternalTableName>springernature</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Depositor Provided PubMed Citations</TOCHeading>
      <Description>A list of PubMed records about this compound, provided by the depositors of all PubChem substance records that are standardized into this compound.</Description>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>Depositor Provided PubMed Citations</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&amp;db=pccompound&amp;cmd=Link&amp;from_uid=358641</URL>
        <Value>
          <ExternalTableName>collection=pubmed&amp;pmidsrcs=xref</ExternalTableName>
          <ExternalTableNumRows>221</ExternalTableNumRows>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Chemical Co-Occurrences in Literature</TOCHeading>
      <Description>Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.</Description>
      <URL>https://doi.org/10.3389/frma.2021.689059</URL>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>Co-Occurrence Panel</Name>
        <Value>
          <StringWithMarkup>
            <String>ChemicalNeighbor</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Chemical</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>ChemicalName_1</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>ChemicalName_2</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>SUMMARY_URL.cid</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Chemical-Gene Co-Occurrences in Literature</TOCHeading>
      <Description>Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.</Description>
      <URL>https://doi.org/10.3389/frma.2021.689059</URL>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>Co-Occurrence Panel</Name>
        <Value>
          <StringWithMarkup>
            <String>ChemicalGeneSymbolNeighbor</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Gene/Protein/Enzyme</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>ChemicalName</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>GeneSymbolName</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>SUMMARY_URL.genesymbol</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>GeneSymbol</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Chemical-Disease Co-Occurrences in Literature</TOCHeading>
      <Description>Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.</Description>
      <URL>https://doi.org/10.3389/frma.2021.689059</URL>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Name>Co-Occurrence Panel</Name>
        <Value>
          <StringWithMarkup>
            <String>ChemicalDiseaseNeighbor</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Disease</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>ChemicalName</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>DiseaseName</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>https://meshb.nlm.nih.gov/record/ui?ui=</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>MeSH</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Patents</TOCHeading>
    <Description>Patent applications/documents that mention this compound.</Description>
    <DisplayControls>
      <ListType>Columns</ListType>
    </DisplayControls>
    <Section>
      <TOCHeading>Depositor-Supplied Patent Identifiers</TOCHeading>
      <Description>Patent identifiers provided by data depositors, along with information on those patents.</Description>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <ExternalTableName>patent</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Link to all deposited patent identifiers</String>
            <Markup>
              <Start>0</Start>
              <Length>40</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/358641/xrefs/PatentID/TXT</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>WIPO PATENTSCOPE</TOCHeading>
      <Description>Use the provided link to show patents associated with this chemical structure in WIPO&apos;s PATENTSCOPE system.</Description>
      <URL>https://www.wipo.int/patentscope/en/</URL>
      <Information>
        <ReferenceNumber>48</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Patents are available for this chemical structure:</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>https://patentscope.wipo.int/search/en/result.jsf?inchikey=WZRJTRPJURQBRM-UHFFFAOYSA-N</String>
            <Markup>
              <Start>0</Start>
              <Length>86</Length>
              <URL>https://patentscope.wipo.int/search/en/result.jsf?inchikey=WZRJTRPJURQBRM-UHFFFAOYSA-N</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Interactions and Pathways</TOCHeading>
    <Description>This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.</Description>
    <Section>
      <TOCHeading>Chemical-Target Interactions</TOCHeading>
      <Description>Interactions between targets and this compound</Description>
      <Information>
        <ReferenceNumber>7</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>9</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Biological Test Results</TOCHeading>
    <Description>A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/docs/widgets</URL>
    <Section>
      <TOCHeading>BioAssay Results</TOCHeading>
      <Description>Bioactivity data for this compound, reported in PubChem BioAssay records.</Description>
      <Information>
        <ReferenceNumber>29</ReferenceNumber>
        <Value>
          <ExternalTableName>bioactivity</ExternalTableName>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Classification</TOCHeading>
    <Description>A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.</Description>
    <Section>
      <TOCHeading>MeSH Tree</TOCHeading>
      <Description>The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.</Description>
      <URL>https://www.nlm.nih.gov/mesh</URL>
      <Information>
        <ReferenceNumber>30</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1</URL>
        <Value>
          <Number>1</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: Drug</TOCHeading>
      <Description>Classification/ontology tree for therapeutic categories of drugs in Japan, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08301</URL>
      <Information>
        <ReferenceNumber>31</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=14</URL>
        <Value>
          <Number>14</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: USP</TOCHeading>
      <Description>US Pharmacopeia (USP) drug classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08302</URL>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=15</URL>
        <Value>
          <Number>15</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: ATC</TOCHeading>
      <Description>Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08303</URL>
      <Information>
        <ReferenceNumber>33</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16</URL>
        <Value>
          <Number>16</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: Drug Groups</TOCHeading>
      <Description>KEGG : Drug Groups tree</Description>
      <Information>
        <ReferenceNumber>39</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96</URL>
        <Value>
          <Number>96</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG : Antimicrobials</TOCHeading>
      <Description>Antiinfectives classification/ontology tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08307</URL>
      <Information>
        <ReferenceNumber>34</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=20</URL>
        <Value>
          <Number>20</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG : Antimicrobials Abbreviations</TOCHeading>
      <Description>KEGG : Antimicrobials Abbreviations tree</Description>
      <Information>
        <ReferenceNumber>43</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=117</URL>
        <Value>
          <Number>117</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>WHO ATC Classification System</TOCHeading>
      <Description>The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.</Description>
      <URL>https://www.who.int/tools/atc-ddd-toolkit/atc-classification</URL>
      <Information>
        <ReferenceNumber>36</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79</URL>
        <Value>
          <Number>79</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>ChemIDplus</TOCHeading>
      <Description>Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).</Description>
      <URL>https://chem.nlm.nih.gov/chemidplus/</URL>
      <Information>
        <ReferenceNumber>37</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84</URL>
        <Value>
          <Number>84</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>ChEMBL Target Tree</TOCHeading>
      <Description>Classification of this entity in the context of targets, provided by ChEMBL.</Description>
      <URL>https://www.ebi.ac.uk/chembl/</URL>
      <Information>
        <ReferenceNumber>38</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87</URL>
        <Value>
          <Number>87</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>EPA DSSTox Classification</TOCHeading>
      <Description>Classification from the U.S. Environmental Protection Agency&apos;s Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. </Description>
      <URL>https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database</URL>
      <Information>
        <ReferenceNumber>40</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105</URL>
        <Value>
          <Number>105</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Drug Type and Pharmacologic Classification</TOCHeading>
      <Description>The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.</Description>
      <Information>
        <ReferenceNumber>42</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116</URL>
        <Value>
          <Number>116</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>EPA Substance Registry Services Tree</TOCHeading>
      <Description>Substance Registry Services (SRS) is the Environmental Protection Agency&apos;s (EPA) central system for information about substances that are tracked or regulated by EPA or other sources. It is a resource for basic information about chemicals, biological organisms, and other substances of interest to EPA and its state and tribal partners. SRS makes it possible to identify which EPA data systems, environmental statutes, or other sources have information about a substance and which synonym is used by that system or statute.</Description>
      <Information>
        <ReferenceNumber>44</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=123</URL>
        <Value>
          <Number>123</Number>
        </Value>
      </Information>
    </Section>
  </Section>
  <Reference>
    <ReferenceNumber>1</ReferenceNumber>
    <SourceName>CAS Common Chemistry</SourceName>
    <SourceID>8064-90-2</SourceID>
    <Name>Sulfamethoxazole-trimethoprim mixt.</Name>
    <Description>CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.</Description>
    <URL>https://commonchemistry.cas.org/detail?cas_rn=8064-90-2</URL>
    <LicenseNote>The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.</LicenseNote>
    <LicenseURL>https://creativecommons.org/licenses/by-nc/4.0/</LicenseURL>
    <ANID>12799923</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>4</ReferenceNumber>
    <SourceName>ChemIDplus</SourceName>
    <SourceID>0008064902</SourceID>
    <Name>Sulfamethoxazole mixture with trimethoprim</Name>
    <Description>ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&amp;sourceid=0008064902</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <IsToxnet>true</IsToxnet>
    <ANID>825040</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>12</ReferenceNumber>
    <SourceName>DTP/NCI</SourceName>
    <SourceID>NSC 618652</SourceID>
    <Name>CO-Trimoxazole</Name>
    <Description>The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.</Description>
    <URL>https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&amp;outputformat=html&amp;searchlist=618652</URL>
    <LicenseNote>Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.</LicenseNote>
    <LicenseURL>https://www.cancer.gov/policies/copyright-reuse</LicenseURL>
    <ANID>6707151</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>13</ReferenceNumber>
    <SourceName>EPA DSSTox</SourceName>
    <SourceID>DTXSID0032233</SourceID>
    <Name>Trimethoprim/sulfamethoxazole</Name>
    <Description>DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.</Description>
    <URL>https://comptox.epa.gov/dashboard/DTXSID0032233</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
    <ANID>1155984</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>16</ReferenceNumber>
    <SourceName>Hazardous Substances Data Bank (HSDB)</SourceName>
    <SourceID>6780</SourceID>
    <Name>TRIMETHOPRIM/SULFAMETHOXAZOLE</Name>
    <Description>The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/6780</URL>
    <LicenseURL>https://www.nlm.nih.gov/web_policies.html</LicenseURL>
    <IsToxnet>true</IsToxnet>
    <ANID>4451</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>2</ReferenceNumber>
    <SourceName>CAS Common Chemistry</SourceName>
    <SourceID>73306-81-7</SourceID>
    <Name>Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, compd. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine (1:1)</Name>
    <Description>CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.</Description>
    <URL>https://commonchemistry.cas.org/detail?cas_rn=73306-81-7</URL>
    <LicenseNote>The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.</LicenseNote>
    <LicenseURL>https://creativecommons.org/licenses/by-nc/4.0/</LicenseURL>
    <ANID>13068376</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>3</ReferenceNumber>
    <SourceName>ChEMBL</SourceName>
    <SourceID>CHEMBL58061::Compound</SourceID>
    <Description>ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.</Description>
    <URL>https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL58061/</URL>
    <LicenseNote>Access to the web interface of ChEMBL is made under the EBI&apos;s Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).</LicenseNote>
    <LicenseURL>http://www.ebi.ac.uk/Information/termsofuse.html</LicenseURL>
    <ANID>25642742</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>5</ReferenceNumber>
    <SourceName>ChemIDplus</SourceName>
    <SourceID>r_134990779</SourceID>
    <Description>The toxicity data was from the legacy RTECS data set in ChemIDplus.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&amp;sourceid=0008064902</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <IsToxnet>true</IsToxnet>
    <ANID>19475919</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>6</ReferenceNumber>
    <SourceName>ClinicalTrials.gov</SourceName>
    <SourceID>cid358641</SourceID>
    <Description>ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.</Description>
    <URL>https://clinicaltrials.gov/</URL>
    <LicenseNote>The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.</LicenseNote>
    <LicenseURL>https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use</LicenseURL>
    <ANID>5186441</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>7</ReferenceNumber>
    <SourceName>Comparative Toxicogenomics Database (CTD)</SourceName>
    <SourceID>D015662::Compound</SourceID>
    <Name>Trimethoprim, Sulfamethoxazole Drug Combination</Name>
    <Description>CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.</Description>
    <URL>https://ctdbase.org/detail.go?type=chem&amp;acc=D015662</URL>
    <LicenseNote>It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.</LicenseNote>
    <LicenseURL>http://ctdbase.org/about/legal.jsp</LicenseURL>
    <ANID>9025159</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>9</ReferenceNumber>
    <SourceName>Drug Gene Interaction database (DGIdb)</SourceName>
    <SourceID>CHEMBL58061_CO-TRIMOXAZOLE</SourceID>
    <Name>CO-TRIMOXAZOLE</Name>
    <Description>The Drug Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that consolidates disparate data sources describing drug - gene interactions and gene druggability.</Description>
    <URL>https://www.dgidb.org/drugs/CO-TRIMOXAZOLE</URL>
    <LicenseNote>The data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.</LicenseNote>
    <LicenseURL>http://www.dgidb.org/downloads</LicenseURL>
    <ANID>19818385</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>23</ReferenceNumber>
    <SourceName>Therapeutic Target Database (TTD)</SourceName>
    <SourceID>D0P0VD</SourceID>
    <Name>Co-trimoxazole</Name>
    <Description>Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.</Description>
    <URL>https://idrblab.net/ttd/data/drug/details/D0P0VD</URL>
    <ANID>19780617</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>8</ReferenceNumber>
    <SourceName>Drug Database, Clinicalinfo.hiv.gov</SourceName>
    <SourceID>hiv_119</SourceID>
    <Name>Sulfamethoxazole / Trimethoprim</Name>
    <Description>The Drug database at the clinicalinfo.hiv.gov contains information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.</Description>
    <URL>https://clinicalinfo.hiv.gov/en/drugs/sulfamethoxazole-trimethoprim/patient</URL>
    <LicenseNote>Unless otherwise noted, material presented on the HIV.gov website is considered Federal government information and is in the public domain. That means this information may be freely copied and distributed. We request that you use appropriate attribution to HIV.gov.</LicenseNote>
    <LicenseURL>https://www.hiv.gov/about-us/mission-and-team</LicenseURL>
    <ANID>15074520</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>20</ReferenceNumber>
    <SourceName>NCI Thesaurus (NCIt)</SourceName>
    <SourceID>C909::Compound</SourceID>
    <Description>NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.</Description>
    <URL>https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C909</URL>
    <LicenseNote>Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.</LicenseNote>
    <LicenseURL>https://www.cancer.gov/policies/copyright-reuse</LicenseURL>
    <ANID>19450214</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>10</ReferenceNumber>
    <SourceName>Drugs and Lactation Database (LactMed)</SourceName>
    <SourceID>LM417</SourceID>
    <Name>Trimethoprim-Sulfamethoxazole</Name>
    <Description>The LactMed(R) database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/</Description>
    <URL>https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM417/</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>24796940</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>18</ReferenceNumber>
    <SourceName>Mother To Baby Fact Sheets</SourceName>
    <SourceID>sulfamethoxazole and trimethoprim</SourceID>
    <Name>sulfamethoxazole and trimethoprim</Name>
    <Description>The MotherToBaby Fact Sheets answer frequently asked questions about many common exposures during pregnancy and breastfeeding, including medications, recreational substances, cosmetic treatments, health conditions, infections, vaccines, and more.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/books/n/mtb/sulfamethoxazole-trimethoprim-en/</URL>
    <LicenseNote>Copyright by OTIS. This work is available under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported license (CC BY-NC-ND 3.0).</LicenseNote>
    <LicenseURL>https://www.ncbi.nlm.nih.gov/books/about/copyright/</LicenseURL>
    <ANID>30371974</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>11</ReferenceNumber>
    <SourceName>Drugs@FDA</SourceName>
    <SourceID>fa_391</SourceID>
    <Name>BACTRIM DS | BACTRIM PEDIATRIC | COTRIM .. total 19</Name>
    <Description>Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.</Description>
    <URL>https://www.accessdata.fda.gov/scripts/cder/daf/</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>30361390</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>14</ReferenceNumber>
    <SourceName>EU Clinical Trials Register</SourceName>
    <SourceID>cid358641</SourceID>
    <Description>The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.</Description>
    <URL>https://www.clinicaltrialsregister.eu/</URL>
    <ANID>6480924</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>15</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>org_358641</SourceID>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>3596325</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>17</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>D00285</SourceID>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>https://www.kegg.jp/entry/D00285</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
    <ANID>31102383</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>19</ReferenceNumber>
    <SourceName>National Drug Code (NDC) Directory</SourceName>
    <SourceID>8dd971e2eb450268251808349d270334</SourceID>
    <Name>SULFAMETHOXAZOLE AND TRIMETHOPRIM</Name>
    <Description>The National Drug Code (NDC) is a unique, three-segment number that serves as FDA&apos;s identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA.</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>31089813</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>21</ReferenceNumber>
    <SourceName>PubChem</SourceName>
    <SourceID>covid19_l_5445</SourceID>
    <URL>https://pubchem.ncbi.nlm.nih.gov</URL>
    <ANID>12497126</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>22</ReferenceNumber>
    <SourceName>Springer Nature</SourceName>
    <SourceID>38061453-123385420</SourceID>
    <Description>Springer Nature is the world&apos;s largest academic book publisher, publisher of the world&apos;s most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=15745&amp;sourceid=38061453-123385420</URL>
    <ANID>3849940</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>24</ReferenceNumber>
    <SourceName>WHO Anatomical Therapeutic Chemical (ATC) Classification</SourceName>
    <SourceID>J01EE01</SourceID>
    <Name>Sulfamethoxazole and trimethoprim</Name>
    <Description>The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.</Description>
    <URL>https://www.whocc.no/atc_ddd_index/?code=J01EE01</URL>
    <LicenseNote>Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.</LicenseNote>
    <LicenseURL>https://www.whocc.no/copyright_disclaimer/</LicenseURL>
    <ANID>24382002</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>25</ReferenceNumber>
    <SourceName>WHO Model Lists of Essential Medicines</SourceName>
    <SourceID>334</SourceID>
    <Name>Sulfamethoxazole + trimethoprim</Name>
    <Description>The WHO Model Lists of Essential Medicines contains the medications considered to be most effective and safe to meet the most important needs in a health system. It has been updated every two years since 1977.</Description>
    <URL>https://list.essentialmeds.org/medicines/334</URL>
    <LicenseNote>WHO supports open access to the published output of its activities as a fundamental part of its mission and a public benefit to be encouraged wherever possible. WHO&apos;s open access applies to WHO  CC BY-NC-SA 3.0 IGO.</LicenseNote>
    <LicenseURL>https://www.who.int/about/who-we-are/publishing-policies/copyright</LicenseURL>
    <ANID>13128133</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>26</ReferenceNumber>
    <SourceName>Wikidata</SourceName>
    <SourceID>Q898623</SourceID>
    <Name>Trimethoprim/sulfamethoxazole</Name>
    <Description>Link to the compound information in Wikidata.</Description>
    <URL>https://www.wikidata.org/wiki/Q898623</URL>
    <LicenseNote>CCZero</LicenseNote>
    <LicenseURL>https://creativecommons.org/publicdomain/zero/1.0/</LicenseURL>
    <ANID>16297694</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>27</ReferenceNumber>
    <SourceName>Wikipedia</SourceName>
    <SourceID>wdQ898623</SourceID>
    <Name>Trimethoprim/sulfamethoxazole</Name>
    <Description>Link to the compound information in Wikipedia.</Description>
    <URL>https://en.wikipedia.org/wiki/Trimethoprim/sulfamethoxazole</URL>
    <ANID>17362076</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>28</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>68015662</SourceID>
    <Name>Trimethoprim, Sulfamethoxazole Drug Combination</Name>
    <Description>MeSH (Medical Subject Headings) is the U.S. National Library of Medicine&apos;s controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/mesh/68015662</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>29</ReferenceNumber>
    <SourceName>PubChem</SourceName>
    <SourceID>PubChem</SourceID>
    <Description>Data deposited in or computed by PubChem</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov</URL>
  </Reference>
  <Reference>
    <ReferenceNumber>30</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>DescTree</SourceID>
    <Name>MeSH Tree</Name>
    <Description>MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>http://www.nlm.nih.gov/mesh/meshhome.html</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>31</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08301</SourceID>
    <Name>Therapeutic category of drugs in Japan</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08301.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>32</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08302</SourceID>
    <Name>USP drug classification</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08302.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>33</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08303</SourceID>
    <Name>Anatomical Therapeutic Chemical (ATC) classification</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08303.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>34</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08307</SourceID>
    <Name>Antiinfectives</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08307.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>36</ReferenceNumber>
    <SourceName>WHO Anatomical Therapeutic Chemical (ATC) Classification</SourceName>
    <SourceID>ATCTree</SourceID>
    <Name>ATC Code</Name>
    <Description>In the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.</Description>
    <URL>https://www.whocc.no/atc_ddd_index/</URL>
    <LicenseNote>Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.</LicenseNote>
    <LicenseURL>https://www.whocc.no/copyright_disclaimer/</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>37</ReferenceNumber>
    <SourceName>ChemIDplus</SourceName>
    <SourceID>ChemIDplus_tree</SourceID>
    <Name>ChemIDplus Chemical Information Classification</Name>
    <Description>ChemIDplus is a TOXNET (TOXicology Data NETwork) databases that contain chemicals and drugs related information. It is a product of the National Library of Medicine (NLM).</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <IsToxnet>true</IsToxnet>
  </Reference>
  <Reference>
    <ReferenceNumber>38</ReferenceNumber>
    <SourceName>ChEMBL</SourceName>
    <SourceID>Target Tree</SourceID>
    <Name>ChEMBL Protein Target Tree</Name>
    <Description>The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 32.</Description>
    <URL>https://www.ebi.ac.uk/chembl/g/#browse/targets</URL>
    <LicenseNote>Access to the web interface of ChEMBL is made under the EBI&apos;s Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).</LicenseNote>
    <LicenseURL>http://www.ebi.ac.uk/Information/termsofuse.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>39</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08330</SourceID>
    <Name>Drug Groups</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08330.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>40</ReferenceNumber>
    <SourceName>EPA DSSTox</SourceName>
    <SourceID>dsstoxlist_tree</SourceID>
    <Name>CompTox Chemicals Dashboard Chemical Lists</Name>
    <Description>This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.&lt;br&gt;Update: 2023-05-16 06:55:01</Description>
    <URL>https://comptox.epa.gov/dashboard/chemical-lists/</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>42</ReferenceNumber>
    <SourceName>National Drug Code (NDC) Directory</SourceName>
    <SourceID>fdandc_tree</SourceID>
    <Name>FDA Drug Type and Pharmacologic Classification</Name>
    <Description>The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>43</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08327</SourceID>
    <Name>Antimicrobials Abbreviations</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08327.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>44</ReferenceNumber>
    <SourceName>EPA Substance Registry Services</SourceName>
    <SourceID>epasrs_tree</SourceID>
    <Name>EPA SRS List Classification</Name>
    <Description>Substance Registry Services (SRS) is the Environmental Protection Agency&apos;s (EPA) central system for information about substances that are tracked or regulated by EPA or other sources. It is a resource for basic information about chemicals, biological organisms, and other substances of interest to EPA and its state and tribal partners. SRS makes it possible to identify which EPA data systems, environmental statutes, or other sources have information about a substance and which synonym is used by that system or statute.</Description>
    <URL>https://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>45</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>68000900</SourceID>
    <Name>Anti-Bacterial Agents</Name>
    <Description>MeSH (Medical Subject Headings) is the U.S. National Library of Medicine&apos;s controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/mesh/68000900</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>46</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>68000892</SourceID>
    <Name>Anti-Infective Agents, Urinary</Name>
    <Description>MeSH (Medical Subject Headings) is the U.S. National Library of Medicine&apos;s controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/mesh/68000892</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>47</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>68000962</SourceID>
    <Name>Antimalarials</Name>
    <Description>MeSH (Medical Subject Headings) is the U.S. National Library of Medicine&apos;s controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/mesh/68000962</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>48</ReferenceNumber>
    <SourceName>PATENTSCOPE (WIPO)</SourceName>
    <Name>SID 388537214</Name>
    <Description>The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/388537214</URL>
  </Reference>
  <Reference>
    <ReferenceNumber>49</ReferenceNumber>
    <SourceName>NCBI</SourceName>
    <SourceID>LinkOut</SourceID>
    <Description>LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/projects/linkout</URL>
  </Reference>
</Record>
